Back to Journals » Vascular Health and Risk Management

Vascular Health and Risk Management


Journal Articles:

- 1,080 records -

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists

Yugar-Toledo JC, Modolo R, de Faria AP, Moreno H

Vascular Health and Risk Management 2017, 13:403-411

Published Date: 16 October 2017

Implementing clinical process management of vascular wounds in a tertiary facility: impact evaluation of a performance improvement project

Avruscio G, Tocco-Tussardi I, Bordignon G, Vindigni V

Vascular Health and Risk Management 2017, 13:393-401

Published Date: 16 October 2017

Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives

Yandrapalli S, Andries G, Biswas M, Khera S

Vascular Health and Risk Management 2017, 13:369-382

Published Date: 5 October 2017

Right ventricular systolic function in hypertensive heart failure

Oketona OA, Balogun MO, Akintomide AO, Ajayi OE, Adebayo RA, Mene-Afejuku TO, Oketona OT, Bamikole OJ

Vascular Health and Risk Management 2017, 13:353-360

Published Date: 27 September 2017

Evaluation of bleeding in patients receiving direct oral anticoagulants

Hellenbart EL, Faulkenberg KD, Finks SW

Vascular Health and Risk Management 2017, 13:325-342

Published Date: 23 August 2017

Endothelial dysfunction in patients with Buerger disease

Igari K, Kudo T, Toyofuku T, Inoue Y

Vascular Health and Risk Management 2017, 13:317-323

Published Date: 23 August 2017

Soluble ST2 correlates with some indicators of right ventricular function in hypertensive heart failure

Ojji DB, Lecour S, Adeyemi OM, Sliwa K

Vascular Health and Risk Management 2017, 13:311-316

Published Date: 16 August 2017

Reversal of direct oral anticoagulants

Almegren M

Vascular Health and Risk Management 2017, 13:287-292

Published Date: 19 July 2017

Hypertension and blood pressure variability management practices among physicians in Singapore

Setia S, Subramaniam K, Tay JC, Teo BW

Vascular Health and Risk Management 2017, 13:275-285

Published Date: 17 July 2017

Quick reference guide to apixaban

Hurst KV, O'Callaghan JM, Handa A

Vascular Health and Risk Management 2017, 13:263-267

Published Date: 10 July 2017

Focusing on a complete blood cell parameter: mean platelet volume levels may be a predictor of coronary slow flow

Yılmaz M, Dağlı MN, Uku Ö, Bilen MN, Korkmaz H, Erdem K, Kurtoğlu E

Vascular Health and Risk Management 2017, 13:255-261

Published Date: 7 July 2017

Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study

Ermini G, Perrone V, Veronesi C, Degli Esposti L, Di Pasquale G

Vascular Health and Risk Management 2017, 13:239-246

Published Date: 5 July 2017

Annual deterioration of renal function in hypertensive patients with and without diabetes

Polonia J, Azevedo A, Monte M, Silva JA, Bertoquini S

Vascular Health and Risk Management 2017, 13:231-237

Published Date: 26 June 2017

Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism

Mesquita PN, Dornelas Leão Leite AP, Chagas Crisostomo S, Veras Filho E, Cunha Xavier L, Bandeira F

Vascular Health and Risk Management 2017, 13:225-229

Published Date: 22 June 2017

Cost-utility analysis comparing laparoscopic vs open aortobifemoral bypass surgery

Krog AH, Sahba M, Pettersen EM, Wisloff T, Sundhagen JO, Kazmi SSH

Vascular Health and Risk Management 2017, 13:217-224

Published Date: 19 June 2017

Comparison of the acute-phase response after laparoscopic versus open aortobifemoral bypass surgery: a substudy of a randomized controlled trial [Erratum]

Krog AH, Sahba M, Pettersen EM, Sandven I, Thorsby PM, Jørgensen JJ, Sundhagen JO, Kazmi SS

Vascular Health and Risk Management 2017, 13:215-216

Published Date: 19 June 2017

Worksite-based cardiovascular risk screening and management: a feasibility study

Padwal R, Rashead M, Snider J, Morrin L, Lehman A, Campbell NRC

Vascular Health and Risk Management 2017, 13:209-213

Published Date: 12 June 2017

Reference values assessment in a Mediterranean population for small dense low-density lipoprotein concentration isolated by an optimized precipitation method

Fernández-Cidón B, Padró-Miquel A, Alía-Ramos P, Castro-Castro MJ, Fanlo-Maresma M, Dot-Bach D, Valero-Politi J, Pintó-Sala X, Candás-Estébanez B

Vascular Health and Risk Management 2017, 13:201-207

Published Date: 6 June 2017

Patient-perceived health-related quality of life before and after laparoscopic aortobifemoral bypass

Kazmi SSH, Krog AH, Berge ST, Sundhagen JO, Sahba M, Falk RS

Vascular Health and Risk Management 2017, 13:169-176

Published Date: 12 May 2017

Infrainguinal open reconstruction: a review of surgical considerations and expected outcomes

Komshian SR, Lu K, Pike SL, Siracuse JJ

Vascular Health and Risk Management 2017, 13:161-168

Published Date: 8 May 2017

Pulmonary hypertension in Nigerian adults with sickle cell anemia

Amadi VN, Balogun MO, Akinola NO, Adebayo RA, Akintomide AO

Vascular Health and Risk Management 2017, 13:153-160

Published Date: 8 May 2017

Impact of around-the-clock in-house cardiology fellow coverage on door-to-balloon time in an academic medical center

Kohan LC, Nagarajan V, Millard MA, Loguidice MJ, Fauber NM, Keeley EC

Vascular Health and Risk Management 2017, 13:139-142

Published Date: 18 April 2017

New pharmacological and technological management strategies in heart failure

Chaudhry SP, Stewart GC

Vascular Health and Risk Management 2017, 13:111-121

Published Date: 21 March 2017

Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device

Alipour A, Wintgens LIS, Swaans MJ, Balt JC, Rensing BJWM, Boersma LVA

Vascular Health and Risk Management 2017, 13:81-90

Published Date: 6 March 2017

Prevalence of mild cognitive impairment in employable patients after acute coronary event in cardiac rehabilitation

Salzwedel A, Heidler MD, Haubold K, Schikora M, Reibis R, Wegscheider K, Jöbges M, Völler H

Vascular Health and Risk Management 2017, 13:55-60

Published Date: 23 February 2017

Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy

Tarantino N, Santoro F, De Gennaro L, Correale M, Guastafierro F, Gaglione A, Di Biase M, Brunetti ND

Vascular Health and Risk Management 2017, 13:29-41

Published Date: 16 February 2017

Complex neurological symptoms in bilateral thalamic stroke due to Percheron artery occlusion

Caruso P, Manganotti P, Moretti R

Vascular Health and Risk Management 2017, 13:11-14

Published Date: 22 December 2016

Inverse relationship of cardioankle vascular index with BMI in healthy Japanese subjects: a cross-sectional study

Nagayama D, Imamura H, Sato Y, Yamaguchi T, Ban N, Kawana H, Ohira M, Saiki A, Shirai K, Tatsuno I

Vascular Health and Risk Management 2017, 13:1-9

Published Date: 21 December 2016

Prevalence of cardiovascular risk factors among workers at a private tertiary center in Angola

Paquissi FC, Manuel V, Manuel A, Mateus GL, David B, Béu G, Castela A

Vascular Health and Risk Management 2016, 12:497-503

Published Date: 14 December 2016

Results of a venous thromboembolism prophylaxis program for hospitalized patients

Cardoso LF, Krokoscz DV, Paiva EF, Furtado IS, Mattar Jr J, de Souza e Sá MM, de Lira AC

Vascular Health and Risk Management 2016, 12:491-496

Published Date: 12 December 2016

Platelet count and platelet indices in women with preeclampsia

AlSheeha MA, Alaboudi RS, Alghasham MA, Iqbal J, Adam I

Vascular Health and Risk Management 2016, 12:477-480

Published Date: 21 November 2016

Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores

Schellings DAAM, Adiyaman A, Dambrink JH, Gosselink ATM, Kedhi E, Roolvink V, Ottervanger JP, van't Hof AWJ

Vascular Health and Risk Management 2016, 12:471-476

Published Date: 21 November 2016

Advances in the management of heart failure: the role of ivabradine

Müller-Werdan U, Stöckl G, Werdan K

Vascular Health and Risk Management 2016, 12:453-470

Published Date: 17 November 2016

A stress-related explanation to the increased blood pressure and its course following ischemic stroke

Kvistad CE, Oygarden H, Logallo N, Thomassen L, Waje-Andreassen U, Moen G, Naess H

Vascular Health and Risk Management 2016, 12:435-442

Published Date: 11 November 2016

Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence

Alhaddad IA, Hamoui O, Hammoudeh A, Mallat S

Vascular Health and Risk Management 2016, 12:407-413

Published Date: 27 October 2016

International normalized ratio self-testing and self-management: improving patient outcomes

Pozzi M, Mitchell J, Henaine AM, Hanna N, Safi O, Henaine R

Vascular Health and Risk Management 2016, 12:387-392

Published Date: 12 October 2016

Carbohydrate composition of circulating multiple-modified low-density lipoprotein

Zakiev ER, Sobenin IA, Sukhorukov VN, Myasoedova VA, Ivanova EA, Orekhov AN

Vascular Health and Risk Management 2016, 12:379-385

Published Date: 14 October 2016

Comparison of the acute-phase response after laparoscopic versus open aortobifemoral bypass surgery: a substudy of a randomized controlled trial

Krog AH, Sahba M, Pettersen EM, Sandven I, Thorsby PM, Jørgensen JJ, Sundhagen JO, Kazmi SS

Vascular Health and Risk Management 2016, 12:371-378

Published Date: 26 September 2016

Overview of guidelines for the management of dyslipidemia: EU perspectives

Giner-Galvañ V, Esteban-Giner MJ, Pallarés-Carratalá V

Vascular Health and Risk Management 2016, 12:357-369

Published Date: 6 September 2016

Critical appraisal of paclitaxel balloon angioplasty for femoral–popliteal arterial disease

Herten M, Torsello GB, Schönefeld E, Stahlhoff S

Vascular Health and Risk Management 2016, 12:341-356

Published Date: 29 August 2016

Risk impact of edoxaban in the management of stroke and venous thromboembolism

Hurst KV, O’Callaghan JM, Handa A

Vascular Health and Risk Management 2016, 12:329-335

Published Date: 11 August 2016

Predictors of high central blood pressure in young with isolated systolic hypertension

Radchenko GD, Torbas OO, Sirenko YM

Vascular Health and Risk Management 2016, 12:321-328

Published Date: 2 August 2016

Effect of nitroglycerin administration on cardio-ankle vascular index

Shimizu K, Yamamoto T, Takahashi M, Sato S, Noike H, Shirai K

Vascular Health and Risk Management 2016, 12:313-319

Published Date: 3 August 2016

Biomarkers and the prediction of atrial fibrillation: state of the art

O’Neal WT, Venkatesh S, Broughton ST, Griffin WF, Soliman EZ

Vascular Health and Risk Management 2016, 12:297-303

Published Date: 18 July 2016

Matrix metalloproteinases in exercise and obesity

Jaoude J, Koh Y

Vascular Health and Risk Management 2016, 12:287-295

Published Date: 14 July 2016

Association between perceived lifetime risk of cardiovascular disease and calculated risk in a male population in Brazil

de Lima Jr MM, da Silva GR, Jansem Filho SS, Granja F

Vascular Health and Risk Management 2016, 12:279-286

Published Date: 22 June 2016

Elevated risk of venous thromboembolic events in patients with inflammatory myopathies

Nowak M, Królak-Nowak K, Sobolewska-Włodarczyk A, Fichna J, Włodarczyk M

Vascular Health and Risk Management 2016, 12:233-238

Published Date: 3 June 2016

Risk factors for amputation in extremities vascular injuries in Saudi Arabia

Al Wahbi A, Aldakhil S, Al Turki S, El Kayali A, Al Kohlani H, Al Showmer A

Vascular Health and Risk Management 2016, 12:229-232

Published Date: 24 May 2016

Cardiovascular risk factor control is insufficient in young patients with coronary artery disease

Christiansen MK, Jensen JM, Brøndberg AK, Bøtker HE, Jensen HK

Vascular Health and Risk Management 2016, 12:219-227

Published Date: 25 May 2016

The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study

Haas S, Holberg G, Kreutz R, Lassen MR, Mantovani L, Haupt V, Vogtländer K, Turpie AGG

Vascular Health and Risk Management 2016, 12:209-218

Published Date: 18 May 2016

PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab

Blom DJ, Dent R, Castro RC, Toth PP

Vascular Health and Risk Management 2016, 12:185-197

Published Date: 9 May 2016

Management of intracerebral hemorrhage – use of statins

Van Matre ET, Sherman DS, Kiser TH

Vascular Health and Risk Management 2016, 12:153-161

Published Date: 18 April 2016

Mortality in primary angioplasty patients starting antiplatelet therapy with prehospital prasugrel or clopidogrel: a 1-year follow-up from the European MULTIPRAC Registry

Goldstein P, Grieco N, Ince H, Danchin N, Ramos Y, Goedicke J, Clemmensen P

Vascular Health and Risk Management 2016, 12:143-151

Published Date: 19 April 2016

Targeting heart failure with preserved ejection fraction: current status and future prospects

Kanwar M, Walter C, Clarke M, Patarroyo-Aponte M

Vascular Health and Risk Management 2016, 12:129-141

Published Date: 15 April 2016

Endovascular revascularization for aortoiliac atherosclerotic disease

Aggarwal V, Waldo SW, Armstrong EJ

Vascular Health and Risk Management 2016, 12:117-127

Published Date: 29 March 2016

Cognitive impairment and stroke in elderly patients

Lo Coco D, Lopez G, Corrao S

Vascular Health and Risk Management 2016, 12:105-116

Published Date: 24 March 2016

Prevalence and correlates of coronary heart disease: first population-based study in Lebanon

Zeidan RK, Farah R, Chahine MN, Asmar R, Hosseini H, Salameh P, Pathak A

Vascular Health and Risk Management 2016, 12:75-84

Published Date: 17 March 2016

Atrial fibrillation and silent stroke: links, risks, and challenges

Hahne K, Mönnig G, Samol A

Vascular Health and Risk Management 2016, 12:65-74

Published Date: 7 March 2016

Type II endoleaks: challenges and solutions

Brown A, Saggu GK, Bown MJ, Sayers RD, Sidloff DA

Vascular Health and Risk Management 2016, 12:53-63

Published Date: 2 March 2016

Edoxaban in venous thromboembolism and stroke prevention: an appraisal

Proietti M, Lip GYH

Vascular Health and Risk Management 2016, 12:45-51

Published Date: 29 February 2016

The cost of inpatient death associated with acute coronary syndrome

Page II RL, Ghushchyan V, Van Den Bos J, Gray TJ, Hoetzer GL, Bhandary D, Nair KV

Vascular Health and Risk Management 2016, 12:13-21

Published Date: 3 February 2016

Critical evaluation of the MitraClip system in the management of mitral regurgitation

Deuschl F, Schofer N, Lubos E, Blankenberg S, Schäfer U

Vascular Health and Risk Management 2016, 12:1-8

Published Date: 11 January 2016

Fractional flow reserve-guided percutaneous coronary intervention: where to after FAME 2?

van de Hoef TP, Meuwissen M, Piek JJ

Vascular Health and Risk Management 2015, 11:613-622

Published Date: 3 December 2015

Personalized medicine and stroke prevention: where are we?

Kim J, Thrift AG, Nelson MR, Bladin CF, Cadilhac DA

Vascular Health and Risk Management 2015, 11:601-611

Published Date: 2 December 2015

Preseason preparation training and endothelial function in elite professional soccer players

Androulakis NE, Koundourakis NE, Nioti E, Spatharaki P, Hatzisymeon D, Miminas I, Alexandrakis MG

Vascular Health and Risk Management 2015, 11:595-599

Published Date: 26 November 2015

Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy

Blaes AH, Rehman A, Vock DM, Luo X, Menge M, Yee D, Missov E, Duprez D

Vascular Health and Risk Management 2015, 11:591-594

Published Date: 24 November 2015

Managing atrial fibrillation in the very elderly patient: challenges and solutions

Karamichalakis N, Letsas KP, Vlachos K, Georgopoulos S, Bakalakos A, Efremidis M, Sideris A

Vascular Health and Risk Management 2015, 11:555-562

Published Date: 27 October 2015

Progression of carotid-artery disease in type 2 diabetic patients: a cohort prospective study

Bosevski M, Stojanovska L

Vascular Health and Risk Management 2015, 11:549-553

Published Date: 16 October 2015

A comparative cohort study of totally laparoscopic and open aortobifemoral bypass for the treatment of advanced atherosclerosis

Kazmi SS, Jørgensen JJ, Sundhagen JO, Krog AH, Flørenes TL, Kollerøs D, Abdelnoor M

Vascular Health and Risk Management 2015, 11:541-547

Published Date: 18 September 2015

The MGuard coronary stent: safety, efficacy, and clinical utility

Gracida M, Romaguera R, Jacobi F, Gómez-Hospital JA, Cequier A

Vascular Health and Risk Management 2015, 11:533-539

Published Date: 18 September 2015

LDL electronegativity index: a potential novel index for predicting cardiovascular disease

Ivanova EA, Bobryshev YV, Orekhov AN

Vascular Health and Risk Management 2015, 11:525-532

Published Date: 28 August 2015

Comparing withdrawal and not withdrawal of life-sustaining treatment among patients who died from stroke

Helvig E, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2015, 11:507-510

Published Date: 3 September 2015

New developments in atherosclerosis: clinical potential of PCSK9 inhibition

Giunzioni I, Tavori H

Vascular Health and Risk Management 2015, 11:493-501

Published Date: 24 August 2015

Subcutaneous adipose tissue plays a beneficial effect on subclinical atherosclerosis in young survivors of acute lymphocytic leukemia

Siviero-Miachon AA, Spinola-Castro AM, Lee ML, Monteiro CM, Carvalho AC, Calixto AR, Geloneze B, Guerra-Junior G

Vascular Health and Risk Management 2015, 11:479-488

Published Date: 18 August 2015

Prevention of venous thromboembolism in patients undergoing bariatric surgery

Bartlett MA, Mauck KF, Daniels PR

Vascular Health and Risk Management 2015, 11:461-477

Published Date: 17 August 2015

Assessing the risk of recurrent venous thromboembolism – a practical approach

Fahrni J, Husmann M, Gretener SB, Keo HH

Vascular Health and Risk Management 2015, 11:451-459

Published Date: 17 August 2015

Secondary stroke prevention: challenges and solutions

Esenwa C, Gutierrez J

Vascular Health and Risk Management 2015, 11:437-450

Published Date: 7 August 2015

Sex differences in predictors of ischemic stroke: current perspectives

Samai AA, Martin-Schild S

Vascular Health and Risk Management 2015, 11:427-436

Published Date: 27 July 2015

Preeclampsia: long-term consequences for vascular health

Amaral LM, Cunningham Jr MW, Cornelius DC, LaMarca B

Vascular Health and Risk Management 2015, 11:403-415

Published Date: 15 July 2015

Feasibility and safety of rehabilitation after venous thromboembolism

Noack F, Schmidt B, Amoury M, Stoevesandt D, Gielen S, Pflaumbaum B, Girschick C, Völler H, Schlitt A

Vascular Health and Risk Management 2015, 11:397-401

Published Date: 13 July 2015

Preoperative optimization of the vascular surgery patient

Zhan HT, Purcell ST, Bush RL

Vascular Health and Risk Management 2015, 11:379-385

Published Date: 1 July 2015

Role of diclofenac in the prevention of postpericardiotomy syndrome after cardiac surgery

Sevuk U, Baysal E, Altindag R, Yaylak B, Adiyaman MS, Ay N, Alp V, Beyazit U

Vascular Health and Risk Management 2015, 11:373-378

Published Date: 30 June 2015

Physical activity in patients with type 2 diabetes and hypertension – insights into motivations and barriers from the MOBILE study

Duclos M, Dejager S, Postel-Vinay N, di Nicola S, Quéré S, Fiquet B

Vascular Health and Risk Management 2015, 11:361-371

Published Date: 29 June 2015

Heart rate variability and arrhythmic patterns of 24-hour Holter electrocardiography among Nigerians with cardiovascular diseases

Adebayo RA, Ikwu AN, Balogun MO, Akintomide AO, Ajayi OE, Adeyeye VO, Mene-Afejuku TO, Bamikole OJ, Ogunyemi SA, Ajibare AO, Oketona OA

Vascular Health and Risk Management 2015, 11:353-359

Published Date: 29 June 2015

Lipidomics in vascular health: current perspectives

Kolovou G, Kolovou V, Mavrogeni S

Vascular Health and Risk Management 2015, 11:333-342

Published Date: 12 June 2015

Blood pressure control to prevent decline in cognition after stroke

Ihle-Hansen H, Thommessen B, Fagerland MW, Øksengård AR, Wyller TB, Engedal K, Fure B

Vascular Health and Risk Management 2015, 11:311-316

Published Date: 9 June 2015

Epoprostenol sodium for treatment of pulmonary arterial hypertension

Saito Y, Nakamura K, Akagi S, Sarashina T, Ejiri K, Miura A, Ogawa A, Matsubara H, Ito H

Vascular Health and Risk Management 2015, 11:265-270

Published Date: 14 May 2015

Lipid-modifying therapy in the elderly

Hamilton-Craig I, Colquhoun D, Kostner K, Woodhouse S, d'Emden M

Vascular Health and Risk Management 2015, 11:251-263

Published Date: 14 May 2015

Alogliptin benzoate for management of type 2 diabetes

Saisho Y

Vascular Health and Risk Management 2015, 11:229-243

Published Date: 10 April 2015

Breast cancer therapy and cardiovascular risk: focus on trastuzumab

Sandoo A, Kitas GD, Carmichael AR

Vascular Health and Risk Management 2015, 11:223-228

Published Date: 7 April 2015

Experimental study of sutureless vascular anastomosis with use of glued prosthesis in rabbits

Vokrri L, Qavdarbasha A, Rudari H, Ahmetaj H, Manxhuka-Kërliu S, Hyseni N, Porcu P, Cinquin P, Sessa C

Vascular Health and Risk Management 2015, 11:211-217

Published Date: 27 March 2015

Virtual reality simulation for the optimization of endovascular procedures: current perspectives

Rudarakanchana N, Van Herzeele I, Desender L, Cheshire NJW

Vascular Health and Risk Management 2015, 11:195-202

Published Date: 10 March 2015

Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease

Chen DC, Armstrong EJ, Singh GD, Amsterdam EA, Laird JR

Vascular Health and Risk Management 2015, 11:185-193

Published Date: 3 March 2015

Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms

Vacek TP, Rehman S, Neamtu D, Yu S, Givimani S, Tyagi SC

Vascular Health and Risk Management 2015, 11:173-183

Published Date: 27 February 2015

Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control

Bays HE, Brinton EA, Triscari J, Chen E, Maccubbin D, MacLean AA, Gibson KL, Ruck RA, Johnson-Levonas AO, O’Neill EA, Mitchel YB

Vascular Health and Risk Management 2015, 11:165-172

Published Date: 24 February 2015

Strokes in young adults: epidemiology and prevention

Smajlović D

Vascular Health and Risk Management 2015, 11:157-164

Published Date: 24 February 2015

Platelet function tests: a comparative review

Paniccia R, Priora R, Alessandrello Liotta A, Abbate R

Vascular Health and Risk Management 2015, 11:133-148

Published Date: 18 February 2015

The role of factor Xa inhibitors in venous thromboembolism treatment

Cabral KP, Ansell JE

Vascular Health and Risk Management 2015, 11:117-123

Published Date: 30 January 2015

Prevention of stent thrombosis: challenges and solutions

Reejhsinghani R, Lotfi AS

Vascular Health and Risk Management 2015, 11:93-106

Published Date: 27 January 2015

Scaffolds in vascular regeneration: current status

Thottappillil N, Nair PD

Vascular Health and Risk Management 2015, 11:79-91

Published Date: 19 January 2015

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups

Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho BL, Ueng KC, DiTommaso S, Shete A

Vascular Health and Risk Management 2015, 11:71-78

Published Date: 21 January 2015

Adiponectin as a potential biomarker of vascular disease

Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini SR, Fallah P, Bazi Z

Vascular Health and Risk Management 2015, 11:55-70

Published Date: 16 January 2015

Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus

Beltrán LM, Rubio-Navarro A, Amaro-Villalobos JM, Egido J, García-Puig J, Moreno JA

Vascular Health and Risk Management 2015, 11:35-48

Published Date: 6 January 2015

Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice

Bramlage P, Fronk EM, Wolf WP, Smolnik R, Sutton G, Schmieder RE

Vascular Health and Risk Management 2015, 11:1-8

Published Date: 17 December 2014

Effects of exercise timing on sleep architecture and nocturnal blood pressure in prehypertensives

Fairbrother K, Cartner B, Alley JR, Curry CD, Dickinson DL, Morris DM, Collier SR

Vascular Health and Risk Management 2014, 10:691-698

Published Date: 12 December 2014

Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction

Claussen PA, Abdelnoor M, Kvakkestad KM, Eritsland J, Halvorsen S

Vascular Health and Risk Management 2014, 10:683-689

Published Date: 9 December 2014

Complications of the endovascular management of acute ischemic stroke

Gill HL, Siracuse JJ, Parrack IK, Huang ZS, Meltzer AJ

Vascular Health and Risk Management 2014, 10:675-681

Published Date: 28 November 2014

Macitentan for the treatment of pulmonary arterial hypertension

Kholdani CA, Fares WH, Trow TK

Vascular Health and Risk Management 2014, 10:665-673

Published Date: 25 November 2014

Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review

Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E

Vascular Health and Risk Management 2014, 10:627-639

Published Date: 7 November 2014

Congenital anomaly of the inferior vena cava and factor V Leiden mutation predisposing to deep vein thrombosis

Lamparello BM, Erickson CR, Kulthia A, Virparia V, Thet Z

Vascular Health and Risk Management 2014, 10:609-613

Published Date: 4 November 2014

Optimal management of infrainguinal arterial occlusive disease

Pennywell DJ, Tan TW, Zhang WW

Vascular Health and Risk Management 2014, 10:599-608

Published Date: 24 October 2014

Consumption of water containing over 3.5 mg of dissolved hydrogen could improve vascular endothelial function

Sakai T, Sato B, Hara K, Hara Y, Naritomi Y, Koyanagi S, Hara H, Nagao T, Ishibashi T

Vascular Health and Risk Management 2014, 10:591-597

Published Date: 17 October 2014

Economic and outcomes consequences of TachoSil®: a systematic review

Colombo GL, Bettoni D, Di Matteo S, Grumi C, Molon C, Spinelli D, Mauro G, Tarozzo A, Bruno GM

Vascular Health and Risk Management 2014, 10:569-576

Published Date: 10 September 2014

Sex differences in long-term outcomes of coronary patients treated with drug-eluting stents at a tertiary medical center

Shammas NW, Shammas GA, Jerin M, Sharis P

Vascular Health and Risk Management 2014, 10:563-568

Published Date: 9 September 2014

Adding multiple risk factors improves Framingham coronary heart disease risk scores

Hu G, Root M, Duncan AW

Vascular Health and Risk Management 2014, 10:557-562

Published Date: 5 September 2014

A three-dimensional electronic report of a venous echo color Doppler of the lower limbs: MEVeC®

Galeandro AI, Scicchitano P, Zito A, Galeandro C, Gesualdo M, Ciciarello F, Cecere A, Marzullo A, Contursi V, Annicchiarico A, Ciccone MM

Vascular Health and Risk Management 2014, 10:549-555

Published Date: 1 September 2014

Perindopril for improving cardiovascular events

DiNicolantonio JJ, O’Keefe JH

Vascular Health and Risk Management 2014, 10:539-548

Published Date: 30 August 2014

Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women

Prasad M, Reriani M, Khosla S, Gössl M, Lennon R, Gulati R, Prasad A, Lerman LO, Lerman A

Vascular Health and Risk Management 2014, 10:533-538

Published Date: 26 August 2014

Thoracoabdominal aortic aneurysm repair: current endovascular perspectives

Orr N, Minion D, Bobadilla JL

Vascular Health and Risk Management 2014, 10:493-505

Published Date: 19 August 2014

Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes

Dardano A, Bianchi C, Del Prato S, Miccoli R

Vascular Health and Risk Management 2014, 10:465-475

Published Date: 5 August 2014

XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation

Camm AJ, Amarenco P, Haas S, Hess S, Kirchhof P, Eickels MV, Turpie AGG

Vascular Health and Risk Management 2014, 10:425-434

Published Date: 17 July 2014

Lower extremity amputation in peripheral artery disease: improving patient outcomes

Swaminathan A, Vemulapalli S, Patel MR, Jones WS

Vascular Health and Risk Management 2014, 10:417-424

Published Date: 16 July 2014

Carotid revascularization: risks and benefits

O'Brien M, Chandra A

Vascular Health and Risk Management 2014, 10:403-416

Published Date: 7 July 2014

Epidemiology of stroke in a rural community in Southeastern Nigeria

Enwereji KO, Nwosu MC, Ogunniyi A, Nwani PO, Asomugha AL, Enwereji EE

Vascular Health and Risk Management 2014, 10:375-388

Published Date: 24 June 2014

Defining risks and predicting adverse events after lower extremity bypass for critical limb ischemia

Siracuse JJ, Huang ZS, Gill HL, Parrack I, Schneider DB, Connolly PH, Meltzer AJ

Vascular Health and Risk Management 2014, 10:367-374

Published Date: 23 June 2014

Update on ranolazine in the management of angina

Codolosa JN, Acharjee S, Figueredo VM

Vascular Health and Risk Management 2014, 10:353-362

Published Date: 24 June 2014

How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study

Penfornis A, Blicklé JF, Fiquet B, Quéré S, Dejager S

Vascular Health and Risk Management 2014, 10:341-352

Published Date: 13 June 2014

Serum lipid profile and its association with hypertension in Bangladesh

Choudhury KN, Mainuddin AKM, Wahiduzzaman M, Islam SMS

Vascular Health and Risk Management 2014, 10:327-332

Published Date: 30 June 2014

Blood and urine levels of heavy metal pollutants in female and male patients with coronary artery disease

Sponder M, Fritzer-Szekeres M, Marculescu R, Mittlböck M, Uhl M, Köhler-Vallant B, Strametz-Juranek J

Vascular Health and Risk Management 2014, 10:311-317

Published Date: 13 May 2014

Validation of the custo screen 400 ambulatory blood pressure-monitoring device according to the European Society of Hypertension International Protocol revision 2010

Bramlage P, Deutsch C, Krüger R, Wolf A, Müller P, Zwingers T, Beime B, Mengden T

Vascular Health and Risk Management 2014, 10:303-309

Published Date: 13 May 2014

Influence of serological factors and BMI on the blood pressure/hematocrit association in healthy young men and women

Salazar Vázquez BY, Salazar Vázquez MA, Chávez-Negrete A, Escobedo G, Cabrales P, Subramaniam S, Intaglietta M, Pérez-Tamayo R

Vascular Health and Risk Management 2014, 10:271-277

Published Date: 6 May 2014

Serum uric acid and target organ damage in essential hypertension

Ofori SN, Odia OJ

Vascular Health and Risk Management 2014, 10:253-261

Published Date: 2 May 2014

The 24-hour pulse wave velocity, aortic augmentation index, and central blood pressure in normotensive volunteers

Kuznetsova TY, Korneva VA, Bryantseva EN, Barkan VS, Orlov AV, Posokhov IN, Rogoza AN

Vascular Health and Risk Management 2014, 10:247-251

Published Date: 28 April 2014

Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

Marrett E, Zhao C, Zhang NJ, Zhang Q, Ramey DR, Tomassini JE, Tershakovec AM, Neff DR

Vascular Health and Risk Management 2014, 10:237-246

Published Date: 25 April 2014

Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study

Azar ST, Hantash HA, Jambart S, El-Zaheri MM, Rachoin R, Chalfoun A, Lahoud L, Okkeh O, Bramlage P, Brudi P, Ambegaonkar BM

Vascular Health and Risk Management 2014, 10:225-235

Published Date: 7 May 2014

Telemonitoring: use in the management of hypertension

Sivakumaran D, Earle KA

Vascular Health and Risk Management 2014, 10:217-224

Published Date: 10 April 2014

Current guidelines for high-density lipoprotein cholesterol in therapy and future directions

Subedi BH, Joshi PH, Jones SR, Martin SS, Blaha MJ, Michos ED

Vascular Health and Risk Management 2014, 10:205-216

Published Date: 8 April 2014

Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations

Jovanovic A, Stolic RV, Rasic DV, Markovic-Jovanovic SR, Peric VM

Vascular Health and Risk Management 2014, 10:201-204

Published Date: 8 April 2014

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty

Levitan B, Yuan Z, Turpie AGG, Friedman RJ, Homering M, Berlin JA, Berkowitz SD, Weinstein RB, DiBattiste PM

Vascular Health and Risk Management 2014, 10:157-167

Published Date: 26 March 2014

The "Pulse Time Index of Norm" highly correlates with the left ventricular mass index in patients with arterial hypertension

Posokhov IN, Kulikova NN, Starchenkova IV, Grigoricheva EA, Evdokimov VV, Orlov AV, Rogoza AN

Vascular Health and Risk Management 2014, 10:139-144

Published Date: 19 March 2014

Challenges associated with peripheral arterial disease in women

Barochiner J, Aparicio LS, Waisman GD

Vascular Health and Risk Management 2014, 10:115-128

Published Date: 10 March 2014

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke

Chapman SN, Mehndiratta P, Johansen MC, McMurry TL, Johnston KC, Southerland AM

Vascular Health and Risk Management 2014, 10:75-87

Published Date: 24 February 2014

Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C – a cross-sectional study

Roed T, Kristoffersen US, Knudsen A, Wiinberg N, Lebech AM, Almdal T, Thomsen RW, Kjær A, Weis N

Vascular Health and Risk Management 2014, 10:55-62

Published Date: 21 January 2014

Is higher body temperature beneficial in ischemic stroke patients with normal admission CT angiography of the cerebral arteries?

Kvistad CE, Khanevski A, Nacu A, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2014, 10:49-54

Published Date: 21 January 2014

Dabigatran and myocardial infarction: a foggy scenario

Pontillo D, Patruno N

Vascular Health and Risk Management 2014, 10:45-48

Published Date: 20 January 2014

Serum lipid profile and correlates in newly presenting Nigerians with arterial hypertension

Adamu UG, Okuku GA, Oladele CO, Abdullahi A, Oduh JI, Fasae AJ

Vascular Health and Risk Management 2013, 9:763-768

Published Date: 3 December 2013

Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients

Daud ZAM, Tubie B, Sheyman M, Osia R, Adams J, Tubie S, Khosla P

Vascular Health and Risk Management 2013, 9:747-761

Published Date: 28 November 2013

Visceral obesity is not an independent risk factor of mortality in subjects over 65 years

Thomas F, Pannier B, Benetos A, Vischer UM

Vascular Health and Risk Management 2013, 9:739-745

Published Date: 22 November 2013

Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk

Lai H, Fishman EK, Gerstenblith G, Moore R, Brinker JA, Keruly JC, Chen S, Detrick B, Lai S

Vascular Health and Risk Management 2013, 9:729-737

Published Date: 15 November 2013

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy

Foody JM, Toth PP, Tomassini JE, Sajjan S, Ramey DR, Neff D, Tershakovec AM, Hu H, Tunceli K

Vascular Health and Risk Management 2013, 9:719-727

Published Date: 15 November 2013

Lipid profiles and inflammatory markers after periodontal treatment in children with congenital heart disease and at risk for atherosclerosis

Bresolin AC, Pronsatti MM, Pasqualotto LN, Nassar PO, Jorge AS, Silva EA, Nassar CA

Vascular Health and Risk Management 2013, 9:703-709

Published Date: 11 November 2013

Titration of amlodipine to higher doses: a comparison of Asian and Western experience

Kario K, Robbins J, Jeffers BW

Vascular Health and Risk Management 2013, 9:695-701

Published Date: 5 November 2013

Linagliptin as add-on therapy to insulin for patients with type 2 diabetes

von Websky K, Reichetzeder C, Hocher B

Vascular Health and Risk Management 2013, 9:681-694

Published Date: 1 November 2013

Postmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery

Kuroda Y, Hirayama C, Hotoda H, Nishikawa Y, Nishiwaki A

Vascular Health and Risk Management 2013, 9:593-598

Published Date: 7 October 2013

Left ventricular dysfunction in normotensive type II diabetic patients in Port Harcourt, Nigeria

Dodiyi-Manuel ST, Akpa MR, Odia OJ

Vascular Health and Risk Management 2013, 9:529-533

Published Date: 25 September 2013

Serum calcium levels are not associated with coronary heart disease

Jin Y, He L, Wang Q, Chen Y, Ren X, Tang H, Song X, Ding L, Qi Q, Huang Z, Yu J, Yao Y

Vascular Health and Risk Management 2013, 9:517-520

Published Date: 3 September 2013

Increased burden and severity of metabolic syndrome and arterial stiffness in treatment naïve HIV+ patients from Cameroon

Ngatchou W, Lemogoum D, Ndobo P, Yagnigni E, Tiogou E, Nga E, Kouanfack C, van de Borne P, Hermans MP

Vascular Health and Risk Management 2013, 9:509-516

Published Date: 4 September 2013

Spanish translation, cross-cultural adaptation, and validation of the Questionnaire for Diabetes-Related Foot Disease (Q-DFD)

Castillo-Tandazo W, Flores-Fortty A, Feraud L, Tettamanti D

Vascular Health and Risk Management 2013, 9:501-508

Published Date: 28 August 2013

Vitamin D deficiency is associated with coronary artery calcification in cardiovascularly asymptomatic African Americans with HIV infection

Lai S, Fishman EK, Gerstenblith G, Brinker J, Tai H, Chen S, Li J, Tong W, Detrick B, Lai H

Vascular Health and Risk Management 2013, 9:493-500

Published Date: 26 August 2013

Perceptions of barriers to cardiac rehabilitation use in Brazil

Ghisi GLM, Santos RZ, Aranha EE, Nunes AD, Oh P, Benetti M, Grace SL

Vascular Health and Risk Management 2013, 9:485-491

Published Date: 30 August 2013

Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice

Bramlage P, Zemmrich C, Ketelhut R, Wolf WP, Fronk EM, Schmieder RE

Vascular Health and Risk Management 2013, 9:475-483

Published Date: 26 August 2013

Current status of NADPH oxidase research in cardiovascular pharmacology

Rodiño-Janeiro BK, Paradela-Dobarro B, Castiñeiras-Landeira MI, Raposeiras-Roubín S, González-Juanatey JR, Álvarez E

Vascular Health and Risk Management 2013, 9:401-428

Published Date: 25 July 2013

The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report

Ferrario CM, Joyner J, Colby C, Exuzides A, Moore M, Simmons D, Bestermann Jr W, Frech-Tamas F

Vascular Health and Risk Management 2013, 9:391-400

Published Date: 22 July 2013

Effects of low-fat dairy intake on blood pressure, endothelial function, and lipoprotein lipids in subjects with prehypertension or stage 1 hypertension

Maki KC, Rains TM, Schild AL, Dicklin MR, Park KM, Lawless AL, Kelley KM

Vascular Health and Risk Management 2013, 9:369-379

Published Date: 23 July 2013

Neutrophil/lymphocyte ratio in patients with atrial septal aneurysm

Demir M, Demir C

Vascular Health and Risk Management 2013, 9:365-368

Published Date: 19 July 2013

Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study

Saifan C, El-Charabaty E, El-Sayegh S

Vascular Health and Risk Management 2013, 9:361-364

Published Date: 17 July 2013

Pattern of sudden death at Ladoke Akintola University of Technology Teaching Hospital, Osogbo, South West Nigeria

Akinwusi PO, Komolafe AO, Olayemi OO, Adeomi AA

Vascular Health and Risk Management 2013, 9:333-339

Published Date: 24 June 2013

Aldosterone receptor antagonists: current perspectives and therapies

Guichard JL, Clark III D, Calhoun DA, Ahmed MI

Vascular Health and Risk Management 2013, 9:321-331

Published Date: 24 June 2013

Statins in heart failure: do we need another trial?

Bonsu KO, Kadirvelu A, Reidpath DD

Vascular Health and Risk Management 2013, 9:303-319

Published Date: 17 June 2013

Persistent middle cerebral artery occlusion associated with lower body temperature on admission

Kvistad CE, Øygarden H, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2013, 9:297-302

Published Date: 17 June 2013

Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin

Steinberg H, Anderson MS, Musliner T, Hanson ME, Engel SS

Vascular Health and Risk Management 2013, 9:273-282

Published Date: 29 May 2013

Current and future initiatives for vascular health management in clinical practice

Cameron JD, Asmar R, Struijker-Boudier H, Shirai K, Sirenko Y, Kotovskaya Y, Topouchian J

Vascular Health and Risk Management 2013, 9:255-264

Published Date: 28 May 2013

Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus

Wang ZS, Song ZC, Bai JH, Li F, Wu T, Qi J, Hu J

Vascular Health and Risk Management 2013, 9:237-243

Published Date: 14 May 2013

Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension

Litvin AY, Sukmarova ZN, Elfimova EM, Aksenova AV, Galitsin PV, Rogoza AN, Chazova IE

Vascular Health and Risk Management 2013, 9:229-235

Published Date: 10 May 2013

Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients

Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E, Rocha E

Vascular Health and Risk Management 2013, 9:207-228

Published Date: 8 May 2013

Endoglin: a critical mediator of cardiovascular health

Kapur NK, Morine KJ, Letarte M

Vascular Health and Risk Management 2013, 9:195-206

Published Date: 6 May 2013

Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department

Sharma RK, Erickson SW, Sharma R, Voelker DJ, Reddy HK, Dod H, Marsh JD

Vascular Health and Risk Management 2013, 9:187-193

Published Date: 1 May 2013

Stress-induced cardiomyopathy (Takotsubo) – broken heart and mind?

Redfors B, Shao Y, Omerovic E

Vascular Health and Risk Management 2013, 9:149-154

Published Date: 17 April 2013

Short-term outcome of patients with preeclampsia

Koual M, Abbou H, Carbonnel M, Picone O, Ayoubi JM

Vascular Health and Risk Management 2013, 9:143-148

Published Date: 15 April 2013

Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently?

Mahabala C, Kamath P, Bhaskaran U, Pai ND, Pai AU

Vascular Health and Risk Management 2013, 9:125-133

Published Date: 24 March 2013

The influence of perivascular adipose tissue on vascular homeostasis

Szasz T, Bomfim GF, Webb RC

Vascular Health and Risk Management 2013, 9:105-116

Published Date: 28 March 2013

Comparison between oscillometric- and Doppler-ABI in elderly individuals

Takahashi I, Furukawa K, Ohishi W, Takahashi T, Matsumoto M, Fujiwara S

Vascular Health and Risk Management 2013, 9:89-94

Published Date: 8 March 2013

Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance

El-Helou N, Al-Hajje A, Ajrouche R, Awada S, Rachidi S, Zein S, Salameh P

Vascular Health and Risk Management 2013, 9:81-88

Published Date: 1 March 2013

Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry

Schaefer JR, Gitt AK, Sonntag F, Weizel A, Jannowitz C, Karmann B, Pittrow D, Bestehorn K

Vascular Health and Risk Management 2013, 9:71-80

Published Date: 21 February 2013

Comparative effect of clopidogrel plus aspirin and aspirin monotherapy on hematological parameters using propensity score matching

Hayasaka M, Takahashi Y, Nishida Y, Yoshida Y, Hidaka S, Asai S

Vascular Health and Risk Management 2013, 9:65-70

Published Date: 18 February 2013

Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

Schweizer A, Foley JE, Kothny W, Ahrén B

Vascular Health and Risk Management 2013, 9:57-64

Published Date: 15 February 2013

Metabolic biomarkers for predicting cardiovascular disease

Montgomery JE, Brown JR

Vascular Health and Risk Management 2013, 9:37-45

Published Date: 29 January 2013

Heel-rise test in the assessment of individuals with peripheral arterial occlusive disease

Monteiro DP, Britto RR, Lages AC, Basílio ML, Pires MC, Carvalho ML, Procópio RJ, Pereira DA

Vascular Health and Risk Management 2013, 9:29-35

Published Date: 23 January 2013

Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment

Lukashevich V, Schweizer A, Foley JE, Dickinson S, Groop PH, Kothny W

Vascular Health and Risk Management 2013, 9:21-28

Published Date: 23 January 2013

Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence

Ferguson C, Inglis SC, Newton PJ, Middleton S, Macdonald PS, Davidson PM

Vascular Health and Risk Management 2013, 9:3-11

Published Date: 17 January 2013

Corrigendum

Basit A, Riaz M, Fawwad A

Vascular Health and Risk Management 2013, 9:1-2

Published Date: 27 December 2012

ESR rate can be a marker for coronary artery disease

Eghbal Eftekhaari T

Vascular Health and Risk Management 2012, 8:669-670

Published Date: 18 December 2012

Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia

Bell DA, Hooper AJ, Watts GF, Burnett JR

Vascular Health and Risk Management 2012, 8:651-659

Published Date: 28 November 2012

Diagnosis of carotid artery stenosis with oculopneumoplethysmography alone and in combination with MRA

Elias RM, Wald JT, Kallmes DF

Vascular Health and Risk Management 2012, 8:631-639

Published Date: 23 November 2012

Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers

Chiquette E, Toth PP, Ramirez G, Cobble M, Chilton R

Vascular Health and Risk Management 2012, 8:621-629

Published Date: 12 November 2012

Treatment of prehypertension: lifestyle and/or medication

Collier SR, Landram MJ

Vascular Health and Risk Management 2012, 8:613-619

Published Date: 15 November 2012

Cerebral blood flow in Alzheimer’s disease

Roher AE, Debbins JP, Malek-Ahmadi M, Chen K, Pipe JG, Maze S, Belden C, Maarouf CL, Thiyyagura P, Mo H, Hunter JM, Kokjohn TA, Walker DG, Kruchowsky JC, Belohlavek M, Sabbagh MN, Beach TG

Vascular Health and Risk Management 2012, 8:599-611

Published Date: 23 October 2012

Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices

Ewen E, Zhang Z, Simon TA, Kolm P, Liu X, Weintraub WS

Vascular Health and Risk Management 2012, 8:587-598

Published Date: 19 October 2012

Prevalence and risk factors associated with peripheral artery disease in elderly patients undergoing peritoneal dialysis

Kuang DW, Li CL, Kuok UI, Cheung K, Lio WI, Xin J

Vascular Health and Risk Management 2012, 8:581-586

Published Date: 19 October 2012

The potential benefit of stem cell therapy after stroke: an update

Banerjee S, Williamson DA, Habib N, Chataway J

Vascular Health and Risk Management 2012, 8:569-580

Published Date: 10 October 2012

The prevention and regression of atherosclerotic plaques: emerging treatments

Kalanuria AA, Nyquist P, Ling G

Vascular Health and Risk Management 2012, 8:549-561

Published Date: 25 September 2012

Diabetes prevalence and metabolic risk profile in an unselected population visiting pharmacies in Switzerland

Rey A, Thoenes M, Fimmers R, Meier CA, Bramlage P

Vascular Health and Risk Management 2012, 8:541-547

Published Date: 21 September 2012

The complex regulation of TGF-ß in cardiovascular disease

Redondo S, Navarro-Dorado J, Ramajo M, Medina Ú, Tejerina T

Vascular Health and Risk Management 2012, 8:533-539

Published Date: 13 September 2012

Rivaroxaban in atrial fibrillation

Giorgi MA, Miguel LS

Vascular Health and Risk Management 2012, 8:525-531

Published Date: 30 August 2012

Ethnicity and acute myocardial infarction: risk profile at presentation, access to hospital management, and outcome in Norway

Abdelnoor M, Eritsland J, Brunborg C, Halvorsen S

Vascular Health and Risk Management 2012, 8:505-515

Published Date: 24 August 2012

The ClaudicatioNet concept: design of a national integrated care network providing active and healthy aging for patients with intermittent claudication

Lauret GJ, Gijsbers HJ, Hendriks EJ, Bartelink ML, de Bie RA, Teijink JA

Vascular Health and Risk Management 2012, 8:495-503

Published Date: 24 August 2012

Disparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patients

Reibis R, Treszl A, Wegscheider K, Bestehorn K, Karmann B, Voeller H

Vascular Health and Risk Management 2012, 8:473-481

Published Date: 17 August 2012

Glimepiride: evidence-based facts, trends, and observations

Basit A, Riaz M, Fawwad A

Vascular Health and Risk Management 2012, 8:463-472

Published Date: 15 August 2012

Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans

Longo-Mbenza B, Nsenga JN, Mokondjimobe E, Gombet T, Assori IN, Ibara JR, Ellenga-Mbolla B, Vangu DN, Fuele SM

Vascular Health and Risk Management 2012, 8:455-461

Published Date: 15 August 2012

Corrigendum

De Caterina AR, Harper AR, Cuculi F

Vascular Health and Risk Management 2012, 8:443-445

Published Date: 19 July 2012

Ezetimibe therapy: mechanism of action and clinical update

Phan BAP, Dayspring TD, Toth PP

Vascular Health and Risk Management 2012, 8:415-427

Published Date: 3 July 2012

Everolimus-eluting stents in interventional cardiology

Townsend JC, Rideout P, Steinberg DH

Vascular Health and Risk Management 2012, 8:393-405

Published Date: 27 June 2012

Lift the quilt in case of atrial fibrillation and disc prolapse

Bastovansky A, Ziegler K, Stöllberger C, Finsterer J

Vascular Health and Risk Management 2012, 8:389-392

Published Date: 22 June 2012

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery

Turpie AG, Schmidt AC, Kreutz R, Lassen MR, Jamal W, Mantovani L, Haas S

Vascular Health and Risk Management 2012, 8:363-370

Published Date: 1 June 2012

Very low levels of HDL cholesterol and atherosclerosis, a variable relationship – a review of LCAT deficiency

Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T

Vascular Health and Risk Management 2012, 8:357-361

Published Date: 5 June 2012

Low body temperature associated with severe ischemic stroke within 6 hours of onset: The Bergen NORSTROKE Study

Kvistad CE, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2012, 8:333-338

Published Date: 1 June 2012

Use of carvedilol in hypertension: an update

Leonetti G, Egan CG

Vascular Health and Risk Management 2012, 8:307-322

Published Date: 18 May 2012

Critical evaluation of the efficacy and tolerability of azilsartan

De Caterina AR, Harper AR, Cuculi F

Vascular Health and Risk Management 2012, 8:299-305

Published Date: 14 May 2012

Percutaneous mechanical thrombectomy for treatment of acute femoropopliteal bypass occlusion

Lichtenberg M, Käunicke M, Hailer B

Vascular Health and Risk Management 2012, 8:283-289

Published Date: 4 May 2012

Lack of a relationship between circulating gamma-glutamyltransferase levels and carotid intima media thickness in hypertensive and diabetic patients

Nuti M, Spontoni P, Grigoratos C, Dell'Omo G, Balbarini A, Pedrinelli R

Vascular Health and Risk Management 2012, 8:275-281

Published Date: 1 May 2012

Treatment patterns and risk factor control in patients with and without metabolic syndrome in cardiac rehabilitation

Gitt A, Jannowitz C, Karoff M, Karmann B, Horack M, Völler H

Vascular Health and Risk Management 2012, 8:265-274

Published Date: 24 April 2012

Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis

Gaebler JA, Soto-Campos G, Alperin P, Cohen M, Blickensderfer A, Wintle M, Maggs D, Hoogwerf B, Han J, Pencek R, Peskin B

Vascular Health and Risk Management 2012, 8:255-264

Published Date: 23 April 2012

Mixed dyslipidemias in primary care patients in France

Laforest L, Ambegaonkar BM, Souchet T, Sazonov V, Van Ganse E

Vascular Health and Risk Management 2012, 8:247-254

Published Date: 19 April 2012

Accuracy of the ankle-brachial index using the SCVL®, an arm and ankle automated device with synchronized cuffs, in a population with increased cardiovascular risk

Rosenbaum D, Rodriguez-Carranza S, Laroche P, Bruckert E, Giral P, Girerd X

Vascular Health and Risk Management 2012, 8:239-246

Published Date: 17 April 2012

The predictive power of depression screening procedures for veterans with coronary artery disease

Shankman SA, Nadelson J, McGowan SK, Sovari AA, Vidovich MI

Vascular Health and Risk Management 2012, 8:233-238

Published Date: 17 April 2012

Correlation of natriuretic peptides and inferior vena cava size in patients with congestive heart failure

Hebl V, Zakharova MY, Canoniero M, Duprez D, Garcia S

Vascular Health and Risk Management 2012, 8:213-218

Published Date: 10 April 2012

Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center

Shammas NW, Shammas GA , Nader E, Jerin M, Mrad L, Marogil P, Henn C, Dvorak A, Chintalapani A, Meriner S

Vascular Health and Risk Management 2012, 8:205-211

Published Date: 11 April 2012

Hemocompatibility of stent materials: alterations in electrical parameters of erythrocyte membranes

Basoli A, Cametti C, Ginnari Satriani F, Mariani P, Severino P

Vascular Health and Risk Management 2012, 8:197-204

Published Date: 21 March 2012

Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients

Mat Daud ZA, Tubie B, Adams J, Quainton T, Osia R, Tubie S, Kaur D, Khosla P, Sheyman M

Vascular Health and Risk Management 2012, 8:187-195

Published Date: 20 March 2012

Barriers to cardiovascular risk prevention and management in Germany – an analysis of the EURIKA study

Schmieder RE, Goebel M, Bramlage P

Vascular Health and Risk Management 2012, 8:177-186

Published Date: 15 March 2012

Major risk factors for the appearance of white-matter lesions on MRI in hypertensive patients with controlled blood pressure

Takami T, Yamano S, Okada S, Sakuma M, Morimoto T, Hashimoto H, Somekawa S, Saito Y

Vascular Health and Risk Management 2012, 8:169-176

Published Date: 14 March 2012

Lower extremity venous thrombosis in patients younger than 50 years of age

Kreidy R, Salameh P, Waked M

Vascular Health and Risk Management 2012, 8:161-167

Published Date: 13 March 2012

Nebivolol: impact on cardiac and endothelial function and clinical utility

Toblli JE, DiGennaro F, Giani JF, Dominici FP

Vascular Health and Risk Management 2012, 8:151-160

Published Date: 13 March 2012

CVD and obesity in transitional Syria: a perspective from the Middle East

Barakat H, Barakat H, Baaj MK

Vascular Health and Risk Management 2012, 8:145-150

Published Date: 6 March 2012

Absorbable stent: focus on clinical applications and benefits

Gonzalo N, Macaya C

Vascular Health and Risk Management 2012, 8:125-132

Published Date: 29 February 2012

Challenges for heart disease stem cell therapy

Hoover-Plow J, Gong Y

Vascular Health and Risk Management 2012, 8:99-113

Published Date: 17 February 2012

Sudden death in eating disorders

Jáuregui-Garrido B, Jáuregui-Lobera I

Vascular Health and Risk Management 2012, 8:91-98

Published Date: 15 February 2012

Evolving role of platelet function testing in coronary artery interventions

Sharma RK, Voelker DJ, Sharma R, Reddy HK, Dod H, Marsh JD

Vascular Health and Risk Management 2012, 8:65-75

Published Date: 8 February 2012

Doppler ultrasound venous mapping of the lower limbs

Galeandro AI, Quistelli G, Scicchitano P, Gesualdo M, Zito A, Caputo P, Carbonara R, Galgano G, Ciciarello F, Mandolesi S, Franceschi C, Ciccone MM

Vascular Health and Risk Management 2012, 8:59-64

Published Date: 7 February 2012

Predictors of poor blood pressure control assessed by 24 hour monitoring in patients with type B acute aortic dissection

Delsart P, Midulla M, Sobocinski J, Achere C, Haulon S, Claisse G, Mounier-Vehier C

Vascular Health and Risk Management 2012, 8:23-30

Published Date: 10 January 2012

Metabolic syndrome and its components associated with endothelial dysfunction in chronic kidney disease patients

Bai Q, Lai X, Zhang AH, Lu XH, Tian SL, Fan MH, Wang Y, Wang T

Vascular Health and Risk Management 2012, 8:15-21

Published Date: 6 January 2012

The impact of diurnal fasting during Ramadan on the lipid profile, hs-CRP, and serum leptin in stable cardiac patients

Khafaji HARH, Bener A, Osman M, Al Merri A, Al Suwaidi J

Vascular Health and Risk Management 2012, 8:7-14

Published Date: 30 December 2011

Blood pressure and blood viscosity are not correlated in normal healthy subjects

Salazar Vázquez BY

Vascular Health and Risk Management 2012, 8:1-6

Published Date: 30 December 2011

Benefits of once-daily therapies in the treatment of hypertension

Flack JM, Nasser SA

Vascular Health and Risk Management 2011, 7:777-787

Published Date: 21 December 2011

The effect of chronic heart failure and type 2 diabetes on insulin-stimulated endothelial function is similar and additive

Falskov B, Hermann TS, Rask-Madsen C, Major-Pedersen A, Christiansen B, Raunsø J, Køber L, Torp-Pedersen C, Dominguez H

Vascular Health and Risk Management 2011, 7:771-776

Published Date: 19 December 2011

Differential clinical profile of candesartan compared to other angiotensin receptor blockers

Cernes R, Mashavi M, Zimlichman R

Vascular Health and Risk Management 2011, 7:749-759

Published Date: 12 December 2011

Critical review of cancer risk associated with angiotensin receptor blocker therapy

Wuerzner G, Burnier M, Waeber B

Vascular Health and Risk Management 2011, 7:741-747

Published Date: 12 December 2011

Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension

Palatini P, Casiglia E, Gąsowski J, Głuszek J, Jankowski P, Narkiewicz K, Saladini F, Stolarz-Skrzypek K, Tikhonoff V, Van Bortel L, Wojciechowska W, Kawecka-Jaszcz K

Vascular Health and Risk Management 2011, 7:725-739

Published Date: 7 December 2011

Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium

Roy SK, Cespedes A, Li D, Choi TY, Budoff MJ

Vascular Health and Risk Management 2011, 7:719-724

Published Date: 2 December 2011

Validation of four automatic devices for self-measurement of blood pressure according to the international protocol of the European Society of Hypertension

Topouchian J, Agnoletti D, Blacher J, Youssef A, Ibanez I, Khabouth J, Khawaja S, Beaino L, Asmar R

Vascular Health and Risk Management 2011, 7:709-717

Published Date: 30 November 2011

Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting

Vogt A, Schoelmerich A, Pollner F, Schlitt M, Raaz U, Maegdefessel L, Reindl I, Buerke M, Werdan K, Schlitt A

Vascular Health and Risk Management 2011, 7:693-699

Published Date: 22 November 2011

Effect of alcohol and tobacco use on vascular dementia: a matched case control study

Takahashi PY, Caldwell CR, Targonski PV

Vascular Health and Risk Management 2011, 7:685-691

Published Date: 15 November 2011

Telmisartan and cardioprotection

Akhrass PR, McFarlane SI

Vascular Health and Risk Management 2011, 7:677-683

Published Date: 15 November 2011

Vitamin D status and peripheral arterial disease: evidence so far

Chua GT, Chan YC, Cheng SW

Vascular Health and Risk Management 2011, 7:671-675

Published Date: 15 November 2011

Hemorrhagic infarction at 33 days after birth in a healthy full-term neonate

Kubo Y, Ogasawara K, Kurose A, Kashimura H, Koji T, Otawara Y, Kamei J, Akasaka M, Sasaki M, Ogawa A

Vascular Health and Risk Management 2011, 7:667-670

Published Date: 8 November 2011

Current state of cardiac rehabilitation in Germany: patient characteristics, risk factor management and control status, by education level

Bestehorn K, Jannowitz C, Horack M, Karmann B, Halle M, Völler H

Vascular Health and Risk Management 2011, 7:639-647

Published Date: 31 October 2011

Effects of smoking cessation on central blood pressure and arterial stiffness

Takami T, Saito Y

Vascular Health and Risk Management 2011, 7:633-638

Published Date: 20 October 2011

Prevalence of significant carotid artery stenosis in Iranian patients with peripheral arterial disease

Bavil AS, Ghabili K, Daneshmand SE, Nemati M, Bavil MS, Namdar H, Shaafi S

Vascular Health and Risk Management 2011, 7:629-632

Published Date: 11 October 2011

Troponin elevation in conditions other than acute coronary syndromes

Tanindi A, Cemri M

Vascular Health and Risk Management 2011, 7:597-603

Published Date: 22 September 2011

Signs for early diagnosis of heart failure in primary health care

Devroey D, Van Casteren V

Vascular Health and Risk Management 2011, 7:591-596

Published Date: 14 September 2011

Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials

Grossman E, Laudon M, Zisapel N

Vascular Health and Risk Management 2011, 7:577-584

Published Date: 15 September 2011

Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention

Pham PA, Pham PT, Pham PC, Miller JM, Pham PM, Pham SV

Vascular Health and Risk Management 2011, 7:551-567

Published Date: 26 August 2011

Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production

Brown MD, Feairheller DL, Thakkar S, Veerabhadrappa P, Park JY

Vascular Health and Risk Management 2011, 7:541-550

Published Date: 26 August 2011

Extended-release ranolazine: critical evaluation of its use in stable angina

Truffa AAM, Newby LK, Melloni C

Vascular Health and Risk Management 2011, 7:535-539

Published Date: 25 August 2011

Lipid-lowering therapy: who can benefit

Lewis SJ

Vascular Health and Risk Management 2011, 7:525-534

Published Date: 24 August 2011

Arterial function of carotid and brachial arteries in postmenopausal vegetarians

Su TC, Torng PL, Jeng JS, Chen MF, Liau CS

Vascular Health and Risk Management 2011, 7:517-523

Published Date: 23 August 2011

Renal artery stenosis in kidney transplants: assessment of the risk factors

Etemadi J, Rahbar K, Haghighi AN, Bagheri N, Falaknazi K, Ardalan MR, Ghabili K, Shoja MM

Vascular Health and Risk Management 2011, 7:503-507

Published Date: 10 August 2011

Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study

Radaideh G, Choueiry P, Ismail A, Eid E, Berrou JP, Sedefdjian A, Sévenier F, Pathak A

Vascular Health and Risk Management 2011, 7:491-495

Published Date: 1 August 2011

Incident prediabetes/diabetes and blood pressure in urban and rural communities in the Democratic Republic of Congo

Hightower JD, Hightower CM, Salazar Vázquez BY, Intaglietta M

Vascular Health and Risk Management 2011, 7:483-489

Published Date: 22 July 2011

Pre-eclampsia: pathophysiology, diagnosis, and management

Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J-M

Vascular Health and Risk Management 2011, 7:467-474

Published Date: 19 July 2011

Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview

Hillegass WB, Brott BC, Dobbs JC, Papapietro SE, Misra VK, Zoghbi GJ

Vascular Health and Risk Management 2011, 7:445-459

Published Date: 18 July 2011

Depression in vascular pathologies: the neurologist's point of view

Moretti R, Bernobich E, Esposito F, Torre P, Antonello RM, De Angelis L, Bellini G

Vascular Health and Risk Management 2011, 7:433-443

Published Date: 12 July 2011

Racial differences in the responses to shear stress in human umbilical vein endothelial cells

Feairheller DL, Park J-Y, Rizzo V, Kim B, Brown MD

Vascular Health and Risk Management 2011, 7:425-431

Published Date: 11 July 2011

Risk factor investigation for cardiovascular health through WHO STEPS approach in Ardabil, Iran

Sadeghi-Bazargani H, Jafarzadeh H, Fallah M, Hekmat S, Bashiri J, Hosseingolizadeh GH, Soltanmohammadzadeh MS, Mortezazadeh A, Shaker A, Danehzan M, Zohouri A, Khosravi O, Nasimidoust R, Malekpour N, Kharazmi E, Babaei M, Nadirmohammadi M, Mashhadi-Abdoll H

Vascular Health and Risk Management 2011, 7:417-424

Published Date: 11 July 2011

Stiffness of the large arteries in individuals with and without Down syndrome

Rodrigues AN, Coelho LC, Goncalves WLS, Gouvea SA, Vasconcellos MJR, Cunha RS, Abreu GR

Vascular Health and Risk Management 2011, 7:375-381

Published Date: 9 June 2011

Chasing the reflected wave back into the heart: a new hypothesis while the jury is still out

Codreanu I, Robson MD, Rider OJ, Pegg TJ, Jung BA, Dasanu CA, Clarke K, Holloway CJ

Vascular Health and Risk Management 2011, 7:365-373

Published Date: 8 June 2011

Stentless aortic valve replacement: an update

Kobayashi J

Vascular Health and Risk Management 2011, 7:345-351

Published Date: 2 June 2011

Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation

Sezer ED, Sozmen EY, Nart D, Onat T

Vascular Health and Risk Management 2011, 7:333-343

Published Date: 1 June 2011

Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods

Barbosa J, Rodrigues A, Mota C, Barbosa M, Simoes e Silva AC

Vascular Health and Risk Management 2011, 7:287-295

Published Date: 10 May 2011

Cognitive evolution in hypertensive patients: a six-year follow-up

Vicario A, del Sueldo MA, Zilberman JM, Cerezo GH

Vascular Health and Risk Management 2011, 7:281-285

Published Date: 5 May 2011

Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta

Xue Y-L, Shi H-X, Murad F, Bian K

Vascular Health and Risk Management 2011, 7:273-280

Published Date: 28 April 2011

Surgery in current therapy for infective endocarditis

Head SJ, Mokhles MM, Osnabrugge RLJ, Bogers AJJC, Kappetein AP

Vascular Health and Risk Management 2011, 7:255-263

Published Date: 19 April 2011

The causes, consequences, and treatment of left or right heart failure

Pazos-Lopez P, Peteiro-Vazquez J, Garcia-Campos A, Garcia-Bueno L, Abugattas-de-Torres JP, Castro-Beiras A

Vascular Health and Risk Management 2011, 7:237-254

Published Date: 4 April 2011

Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program

Abraham I, MacDonald K, Hermans C, Aerts A, Lee C, Brié H, Vancayzeele S

Vascular Health and Risk Management 2011, 7:209-235

Published Date: 31 March 2011

Doppler study of cerebral arteries in hypercholesterolemia

Farhoudi M, Mehrvar K, Aslanabadi N, Ghabili K, Baghmishe NR, Ilkhchoei F

Vascular Health and Risk Management 2011, 7:203-207

Published Date: 31 March 2011

The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation

Schmidt C, Kisselbach J, Schweizer PA, Katus HA, Thomas D

Vascular Health and Risk Management 2011, 7:193-202

Published Date: 31 March 2011

Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders

Mingorance C, Rodríguez-Rodríguez R, Justo ML, Alvarez de Sotomayor M, Herrera MD

Vascular Health and Risk Management 2011, 7:169-176

Published Date: 28 March 2011

Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications

Carlos V Serrano Jr, Karina Tiemi Setani, Erica Sakamoto, et al

Vascular Health and Risk Management 2011, 7:159-164

Published Date: 16 March 2011

Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome – a comprehensive cancer center experience

Hikmat N Abdel-Razeq, Asem H Mansour, Yousef M Ismael

Vascular Health and Risk Management 2011, 7:153-158

Published Date: 15 March 2011

Skeletonized coronary arteries: pathophysiological and clinical aspects of vascular calcification

Carlos V Serrano Jr, Marcelo Oranges, Vitor Brunaldi, et al

Vascular Health and Risk Management 2011, 7:143-151

Published Date: 9 March 2011

Treatment options for hypertension in high-risk patients

Wei-Chuan Tsai

Vascular Health and Risk Management 2011, 7:137-141

Published Date: 9 March 2011

Coronary sinus intervention for the treatment of refractory angina pectoris

Yoav Paz, Amihay Shinfeld

Vascular Health and Risk Management 2011, 7:135-136

Published Date: 3 March 2011

Cardiovascular risk evaluation and prevalence of silent myocardial ischemia in subjects with asymptomatic carotid artery disease

Marco Matteo Ciccone, Asabella Artor Niccoli, Pietro Scicchitano, et al

Vascular Health and Risk Management 2011, 7:129-134

Published Date: 4 March 2011

Novel drug-eluting stents in the treatment of de novo coronary lesions

Davide Capodanno, Fabio Dipasqua, Corrado Tamburino

Vascular Health and Risk Management 2011, 7:103-118

Published Date: 25 February 2011

Endothelial function in a cardiovascular risk population with borderline ankle–brachial index

Kari Syvänen, Päivi Korhonen, Auli Partanen, et al

Vascular Health and Risk Management 2011, 7:97-101

Published Date: 23 February 2011

Decline of arterial cerebral infarction among young women: the Bergen Stroke Study

Halvor Naess, Annette Fromm, Ole Erik Iversen, et al

Vascular Health and Risk Management 2011, 7:81-84

Published Date: 15 February 2011

Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus

Samuel O Olusi, Sunila George

Vascular Health and Risk Management 2011, 7:75-80

Published Date: 15 February 2011

Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study

Ersen B Colkesen, Bart S Ferket, Jan GP Tijssen, et al

Vascular Health and Risk Management 2011, 7:67-74

Published Date: 9 February 2011

Relevance of tumor angiogenesis patterns as a diagnostic value and prognostic indicator in oral precancer and cancer

Devi Charan Shetty, Puneet Ahuja, DK Taneja, et al

Vascular Health and Risk Management 2011, 7:41-47

Published Date: 27 January 2011

Congenital agenesis of internal carotid artery with ipsilateral Horner presenting as focal neurological symptoms

Wassim Farhat, Rechdi Ahdab, Hassan Hosseini

Vascular Health and Risk Management 2011, 7:37-40

Published Date: 26 January 2011

Hyperhomocysteinemia decreases bone blood flow

Neetu Tyagi, Thomas P Vacek, John T Fleming, et al

Vascular Health and Risk Management 2011, 7:31-35

Published Date: 25 January 2011

Antiplatelet combinations for prevention of atherothrombotic events

Mario Bollati, Fiorenzo Gaita, Matteo Anselmino

Vascular Health and Risk Management 2011, 7:23-30

Published Date: 12 January 2011

ACE up the sleeve – are vascular patients medically optimized

AP Coveney, GC O'Brien, GJ Fulton

Vascular Health and Risk Management 2011, 7:15-21

Published Date: 7 January 2011

COSEHC global vascular risk management quality improvement program: rationale and design

Carlos M Ferrario, Michael A Moore, William Bestermann Jr, et al

Vascular Health and Risk Management 2010, 6:1135-1145

Published Date: 13 December 2010

Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing

Emily Dey-Hazra, Barbara Hertel, Torsten Kirsch, et al

Vascular Health and Risk Management 2010, 6:1125-1133

Published Date: 6 December 2010

Inhaled treprostinil and pulmonary arterial hypertension

Samuel T Nadler, Jeffrey D Edelman

Vascular Health and Risk Management 2010, 6:1115-1124

Published Date: 3 December 2010

Lower extremity arterial injuries over a six-year period: outcomes, risk factors, and management

Aşkin Ender Topal, Mehmet Nesimi Eren, Yusuf Celik

Vascular Health and Risk Management 2010, 6:1103-1110

Published Date: 3 December 2010

Insulin therapy in critically ill patients

Samer Ellahham

Vascular Health and Risk Management 2010, 6:1089-1101

Published Date: 1 December 2010

Optimal management of familial hypercholesterolemia: treatment and management strategies

Mohammad Hassan Nemati, Behrooz Astaneh

Vascular Health and Risk Management 2010, 6:1079-1088

Published Date: 3 December 2010

Percutaneous coronary intervention of a single coronary artery arising from the right sinus of Valsalva

Mehmet Akif Cakar, Ersan Tatli, Bilhan Ozalp, et al

Vascular Health and Risk Management 2010, 6:1077-1078

Published Date: 25 November 2010

Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy

William Insull Jr, Peter P Toth, H Robert Superko, et al

Vascular Health and Risk Management 2010, 6:1065-1075

Published Date: 24 November 2010

Cardio classics revisited – focus on the role of candesartan

Maria Leonarda De Rosa

Vascular Health and Risk Management 2010, 6:1047-1063

Published Date: 23 November 2010

Computerized history-taking as a tool to manage dyslipidemia

David Zakim, Christine Fritz, Niko Braun, et al

Vascular Health and Risk Management 2010, 6:1039-1046

Published Date: 12 November 2010

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia

Ian Hamilton-Craig, Karam Kostner, David Colquhoun, et al

Vascular Health and Risk Management 2010, 6:1023-1037

Published Date: 10 November 2010

Prognostic value of changes in arterial stiffness in men with coronary artery disease

Iana A Orlova, Eradzh Yu Nuraliev, Elena B Yarovaya, et al

Vascular Health and Risk Management 2010, 6:1015-1021

Published Date: 4 November 2010

Effects of safflower seed extract on arterial stiffness

Katsuya Suzuki, Shigekazu Tsubaki, Masami Fujita, et al

Vascular Health and Risk Management 2010, 6:1007-1014

Published Date: 3 November 2010

Low high-density lipoprotein cholesterol: current status and future strategies for management

Vibhuti Singh, Rakesh Sharma, Ajoy Kumar, et al

Vascular Health and Risk Management 2010, 6:979-996

Published Date: 29 October 2010

Hypothyroidism and the risk of lower extremity arterial disease

Michael A Mazzeffi, Hung-Mo Lin, Brigid C Flynn, et al

Vascular Health and Risk Management 2010, 6:957-962

Published Date: 20 October 2010

Risk assessment and aspirin use in Asian and Western populations

Runlin Gao, Xiaoying Li

Vascular Health and Risk Management 2010, 6:943-956

Published Date: 14 October 2010

Diagnostic accuracy of dual-source CT angiography and coronary risk stratification

Xia Yang, Lu-yue Gai, Ping Li, et al

Vascular Health and Risk Management 2010, 6:935-941

Published Date: 14 October 2010

Impact of a diabetic foot care education program on lower limb amputation rate

Abdullah M Al-Wahbi

Vascular Health and Risk Management 2010, 6:923-934

Published Date: 11 October 2010

Costs and outcomes of noncardioembolic ischemic stroke in a managed care population

Nicole M Engel-Nitz, Stephen D Sander, Carolyn Harley, et al

Vascular Health and Risk Management 2010, 6:905-913

Published Date: 5 October 2010

Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies

Christina Voulgari, Dimitrios Papadogiannis, Nicholas Tentolouris

Vascular Health and Risk Management 2010, 6:883-903

Published Date: 11 October 2010

New class of agents for treatment of hypertension: Focus on direct renin inhibition

Roberto Fogari, Annalisa Zoppi

Vascular Health and Risk Management 2010, 6:869-882

Published Date: 1 October 2010

Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update

Juan V Llau, Raquel Ferrandis, Pilar Sierra, et al

Vascular Health and Risk Management 2010, 6:855-867

Published Date: 29 September 2010

Benefits of statin therapy and compliance in high risk cardiovascular patients

Joel A Lardizabal, Prakash C Deedwania

Vascular Health and Risk Management 2010, 6:843-853

Published Date: 23 September 2010

Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study

Laura J Gray, Jennifer R Tringham, Melanie J Davies, et al

Vascular Health and Risk Management 2010, 6:837-842

Published Date: 20 September 2010

Argatroban in the management of heparin-induced thrombocytopenia

Luciano Babuin, Vittorio Pengo

Vascular Health and Risk Management 2010, 6:813-819

Published Date: 1 September 2010

Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice

Peter Bramlage, Wolf-Peter Wolf, Thomas Stuhr, et al

Vascular Health and Risk Management 2010, 6:803-811

Published Date: 27 August 2010

Role of endothelin receptor A and NADPH oxidase in vascular abnormalities

De-Zai Dai, Yin Dai

Vascular Health and Risk Management 2010, 6:787-794

Published Date: 3 September 2010

Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review

Suzanne A Ligthart, Eric P Moll van Charante, Willem A Van Gool, et al

Vascular Health and Risk Management 2010, 6:775-785

Published Date: 17 August 2010

Effectiveness of percutaneous laser revascularization therapy for refractory angina

Michael McGillion, Allison Cook, J Charles Victor, et al

Vascular Health and Risk Management 2010, 6:735-747

Published Date: 26 August 2010

Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells

Myriam Iglewski, Stephen R Grant

Vascular Health and Risk Management 2010, 6:723-734

Published Date: 11 August 2010

Role of olmesartan in combination therapy in blood pressure control and vascular function

Carlos M Ferrario, Ronald D Smith

Vascular Health and Risk Management 2010, 6:701-709

Published Date: 9 August 2010

Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment

Curtis Triplitt, Eugenio Cersosimo, Ralph A DeFronzo

Vascular Health and Risk Management 2010, 6:671-690

Published Date: 5 August 2010

Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction

Elmir Omerovic, Truls Råmunddal, Per Albertsson, et al

Vascular Health and Risk Management 2010, 6:657-663

Published Date: 26 August 2010

Estimating glomerular filtration rate in a population-based study

Anoop Shankar, Kristine E Lee, Barbara EK Klein, et al

Vascular Health and Risk Management 2010, 6:619-627

Published Date: 16 July 2010

Management of high-risk popliteal vascular blunt trauma: clinical experience with 62 cases

Ali Pourzand, Bassir A Fakhri, Ramin Azhough, et al

Vascular Health and Risk Management 2010, 6:613-618

Published Date: 14 July 2010

Cardiac risk stratification: Role of the coronary calcium score

Rakesh K Sharma, Rajiv K Sharma, Donald J Voelker, et al

Vascular Health and Risk Management 2010, 6:603-611

Published Date: 14 July 2010

Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy

Claudio A Muratore, Adrian Baranchuk

Vascular Health and Risk Management 2010, 6:593-601

Published Date: 14 July 2010

Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome

Kanako Bokuda, Atsuhiro Ichihara, Mariyo Sakoda, et al

Vascular Health and Risk Management 2010, 6:571-578

Published Date: 5 July 2010

Practical recommendations for treatment of hypertension in older patients

Philip A Kithas, Mark A Supiano

Vascular Health and Risk Management 2010, 6:561-569

Published Date: 29 June 2010

Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination

Francesca Cagnoni, Christian Achiri Ngu Njwe, Augusto Zaninelli, et al

Vascular Health and Risk Management 2010, 6:549-559

Published Date: 28 June 2010

Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid

Elisavet Moutzouri, Anastazia Kei, Moses S Elisaf, et al

Vascular Health and Risk Management 2010, 6:525-539

Published Date: 29 June 2010

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy

Deborah Wolbrette, Mario Gonzalez, Soraya Samii, et al

Vascular Health and Risk Management 2010, 6:517-523

Published Date: 28 June 2010

Clinical profile of hypertension at a University Teaching Hospital in Nigeria

Arthur C Onwuchekwa, Sunday Chinenye

Vascular Health and Risk Management 2010, 6:511-516

Published Date: 1 July 2010

Transradial approach to lower extremity interventions

Ravikiran Korabathina, Sidharth S Yadav, John T Coppola, et al

Vascular Health and Risk Management 2010, 6:503-509

Published Date: 1 July 2010

Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG

Sandra Eifert, Helmut Mair, Anne-Laure Boulesteix, et al

Vascular Health and Risk Management 2010, 6:495-501

Published Date: 29 June 2010

Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection

Domenico Galzerano, Cristina Capogrosso, Sara Di Michele, et al

Vascular Health and Risk Management 2010, 6:479-494

Published Date: 22 June 2010

Congestive heart failure in subjects with thyrotoxicosis in a black community

R C Anakwue, B J C Onwubere, B C Anisiuba, et al

Vascular Health and Risk Management 2010, 6:473-477

Published Date: 5 July 2010

Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure

Inder S Anand, Anita Deswal, Dean J Kereiakes, et al

Vascular Health and Risk Management 2010, 6:449-455

Published Date: 1 June 2010

Novel approaches for the surgical treatment of atrial fibrillation: Time for a guideline revision?

Carlo Nicola De Cecco, Vitaliano Buffa, Vincenzo David, et al

Vascular Health and Risk Management 2010, 6:439-447

Published Date: 9 June 2010

Influence of demographic and metabolic variables on forearm blood flow and vascular conductance in individuals without overt heart disease

Thiago E Sartori, Rafael AB Nunes, Gisela T da Silva, et al

Vascular Health and Risk Management 2010, 6:431-437

Published Date: 31 May 2010

Novel antiplatelet agents in the prevention of cardiovascular complications – focus on ticagrelor

Margaret M Marczewski, Marek Postula, Dariusz Kosior

Vascular Health and Risk Management 2010, 6:419-429

Published Date: 24 May 2010

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure

A Palazzuoli, M Gallotta, I Quatrini, et al

Vascular Health and Risk Management 2010, 6:411-418

Published Date: 26 May 2010

Heart rate control with adrenergic blockade: Clinical outcomes in cardiovascular medicine

David Feldman, Terry S Elton, Doron M Menachemi, et al

Vascular Health and Risk Management 2010, 6:387-397

Published Date: 24 May 2010

Isolated spontaneous dissection of the celiac trunk in a patient with bicuspid aortic valve

Abdel-Rauf Zeina, Alicia Nachtigal, Anton Troitsa, et al

Vascular Health and Risk Management 2010, 6:383-386

Published Date: 19 May 2010

Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes

Magnus Dencker, Martin Stagmo, Mozhgan Dorkhan

Vascular Health and Risk Management 2010, 6:373-382

Published Date: 18 May 2010

New options with dabigatran etexilate in anticoagulant therapy

Lars Maegdefessel, Joshua M Spin, Junya Azuma, et al

Vascular Health and Risk Management 2010, 6:339-349

Published Date: 10 May 2010

Should we screen for masked hypertension in patient with vascular disease?

Pascal Delsart, Philippe Marboeuf, Cedric Delhaye, et al

Vascular Health and Risk Management 2010, 6:333-338

Published Date: 10 May 2010

Effect of lipopenic and hypotensive treatment on homocysteine levels in type 2 diabetics

Mabrouka El Oudi, Zied Aouni, Haroun Ouertani, et al

Vascular Health and Risk Management 2010, 6:327-332

Published Date: 13 May 2010

Volumetric capnography: In the diagnostic work-up of chronic thromboembolic disease

Marcos Mello Moreira, Renato Giuseppe Giovanni Terzi, Laura Cortellazzi, et al

Vascular Health and Risk Management 2010, 6:317-319

Published Date: 17 May 2010

Coronary computed tomographic angiography (CCTA) in community hospitals: “current and emerging role”

Rakesh K Sharma, Donald J Voelker, Rajiv K Sharma, et al

Vascular Health and Risk Management 2010, 6:307-316

Published Date: 10 May 2010

Mortality following operations for lower extremity peripheral arterial disease

Tracie C Collins, David Nelson, Jasjit S Ahluwalia

Vascular Health and Risk Management 2010, 6:287-296

Published Date: 3 May 2010

Predictors of obstructive sleep apnea in males with metabolic syndrome

Nikolaos Papanas, Paschalis Steiropoulos, Evangelia Nena, et al

Vascular Health and Risk Management 2010, 6:281-286

Published Date: 20 April 2010

The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension

Jeremy A Falk, Kiran J Philip, Ernst R Schwarz

Vascular Health and Risk Management 2010, 6:273-280

Published Date: 20 April 2010

Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update

Maurizio Destro, Francesca Cagnoni, Antonio D’Ospina, et al

Vascular Health and Risk Management 2010, 6:253-260

Published Date: 14 April 2010

Managing anemia in patients with chronic heart failure: what do we know?

Ankur Sandhu, Sandeep Soman, Michael Hudson, et al

Vascular Health and Risk Management 2010, 6:237-252

Published Date: 7 April 2010

Atorvastatin in stroke: a review of SPARCL and subgroup analysis

Branko N Huisa, Andrew B Stemer, Justin A Zivin

Vascular Health and Risk Management 2010, 6:229-236

Published Date: 30 March 2010

Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function

Poulami Basu, Utpal Sen, Neetu Tyagi,  et al

Vascular Health and Risk Management 2010, 6:215-228

Published Date: 30 March 2010

Recent achievements in the management of Raynaud’s phenomenon

Magnus Baumhäkel, Michael Böhm

Vascular Health and Risk Management 2010, 6:207-214

Published Date: 30 March 2010

Does plasmin have anticoagulant activity?

Jane Hoover-Plow

Vascular Health and Risk Management 2010, 6:199-205

Published Date: 26 March 2010

Advances in the treatment of Raynaud’s phenomenon

Terri L Levien

Vascular Health and Risk Management 2010, 6:167-177

Published Date: 11 March 2010

Prevalence and risk factors of microalbuminuria in Thai nondiabetic hypertensive patients

Pongsathorn Gojaseni, Angkana Phaopha, Worawon Chailimpamontree, et al

Vascular Health and Risk Management 2010, 6:157-165

Published Date: 11 March 2010

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

Ajikumar V Aryangat, John E Gerich

Vascular Health and Risk Management 2010, 6:145-155

Published Date: 9 March 2010

The diagnostic value of endothelial function as a potential sensor of fatigue in health

Yoshiko Ohno, Teruto Hashiguchi, Ryuichi Maenosono, et al

Vascular Health and Risk Management 2010, 6:135-144

Published Date: 9 March 2010

New standards in hypertension and cardiovascular risk management: focus on telmisartan

Domenico Galzerano, Cristina Capogrosso, Sara Di Michele, et al

Vascular Health and Risk Management 2010, 6:113-133

Published Date: 4 March 2010

A newly designed hydroxyapatite ceramic burr-hole button

Hiroshi Kashimura, Kuniaki Ogasawara, Yoshitaka Kubo, et al

Vascular Health and Risk Management 2010, 6:105-108

Published Date: 3 March 2010

Modern role for clopidogrel in management of atrial fibrillation and stroke reduction

Lars Maegdefessel, Junya Azuma, Philip S Tsao

Vascular Health and Risk Management 2010, 6:95-103

Published Date: 26 February 2010

On the antiatherogenic effects of vitamin E: the search for the Holy Grail

Francesco Galli, Dimitrios Kirmizis, Dimitrios Chatzidimitriou

Vascular Health and Risk Management 2010, 6:69-71

Published Date: 16 February 2010

Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention

Jennifer Vergara-Jimenez, Pierluigi Tricoci

Vascular Health and Risk Management 2010, 6:39-45

Published Date: 2 March 2010

Successful management of late right ventricular perforation after pacemaker implantation

Amir K Bigdeli, Andres Beiras-Fernandez, Ingo Kaczmarek, et al

Vascular Health and Risk Management 2010, 6:27-30

Published Date: 6 January 2010

Role of ICAM-1 and E-selectin gene polymorphisms in pathogenesis of PAOD in Egyptian patients

Olfat Shaker, Amr Zahra, Ahmed Sayed, et al

Vascular Health and Risk Management 2010, 6:9-15

Published Date: 24 December 2009

Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients

Jamison Wyatt, Shailesh Nandish, Rene Oliveros, et al

Vascular Health and Risk Management 2010, 6:1-8

Published Date: 23 December 2009

Nitric oxide and coronary vascular endothelium adaptations in hypertension

Andrew S Levy, Justin CS Chung, Jeffrey T Kroetsch, et al

Vascular Health and Risk Management 2009, 5:1075-1087

Published Date: 16 December 2009

Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea

Jean-Philippe Baguet, Marie Nadra, Gilles Barone-Rochette, et al

Vascular Health and Risk Management 2009, 5:1063-1073

Published Date: 11 December 2009

Persistent high fever and systemic inflammation induced by percutaneous coronary intervention-related periaortitis

Takamori Kakino, Tomohiro Nakayama, Hideo Yamamoto

Vascular Health and Risk Management 2009, 5:1059-1062

Published Date: 8 December 2009

Mitigating micro- and macro-vascular complications of diabetes beginning in adolescence

Daniel J Moore, Justin M Gregory, Yaa A Kumah-Crystal, et al

Vascular Health and Risk Management 2009, 5:1015-1031

Published Date: 18 November 2009

Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India

Krishna K Sharma, Rajeev Gupta, Aachu Agrawal, et al

Vascular Health and Risk Management 2009, 5:1007-1014

Published Date: 20 November 2009

Seasonal hematocrit variation and health risks in the adult population of Kinshasa, Democratic Republic of Congo

C Makena Hightower, Joyce D Hightower, Beatriz Y Salazar Vázquez, et al

Vascular Health and Risk Management 2009, 5:1001-1005

Published Date: 17 November 2009

Vascular health in children and adolescents: effects of obesity and diabetes

Kevin R Short, Piers R Blackett, Andrew W Gardner, et al

Vascular Health and Risk Management 2009, 5:973-990

Published Date: 10 November 2009

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting

Rakesh K Sharma, Hanumanth K Reddy, Vibhuti N Singh, et al

Vascular Health and Risk Management 2009, 5:965-972

Published Date: 9 November 2009

The treatment of diabetic foot infections: focus on ertapenem

Michael Edmonds

Vascular Health and Risk Management 2009, 5:949-963

Published Date: 6 November 2009

Comparative assessment of angiotensin receptor blockers in different clinical settings

Paolo Verdecchia, Fabio Angeli, Salvatore Repaci, et al

Vascular Health and Risk Management 2009, 5:939-948

Published Date: 6 November 2009

Erratum

Zeina AR, Slobodin G, Naschitz JE et al.

Vascular Health and Risk Management 2009, 5:937-938

Published Date: 3 November 2009

Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea

Sanja Jelic,  David J Lederer, Tessa Adams, et al.

Vascular Health and Risk Management 2009, 5:909-920

Published Date: 3 November 2009

Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes

Nikolaos Östlund Papadogeorgos, Mattias Bengtsson, Majid Kalani

Vascular Health and Risk Management 2009, 5:893-899

Published Date: 28 October 2009

Randomized study to compare valsartan ± HCTZ versus amlodipine ± HCTZ strategies to maximize blood pressure control

Dion Zappe, Cheraz Cherif Papst, Philippe Ferber, et al.

Vascular Health and Risk Management 2009, 5:883-892

Published Date: 22 October 2009

Treatment of congenital fibrinogen deficiency: overview and recent findings

Konstantinos Tziomalos, Sofia Vakalopoulou, Vassilios Perifanis, et al

Vascular Health and Risk Management 2009, 5:843-848

Published Date: 5 October 2009

Ankle Brachial Pressure Index (ABPI): An update for practitioners

Mo Al-Qaisi, David M Nott, David H King, et al

Vascular Health and Risk Management 2009, 5:833-841

Published Date: 30 September 2009

Update on the clinical use of the low-molecular-weight heparin, parnaparin

Giuseppe Camporese, Enrico Bernardi, Franco Noventa

Vascular Health and Risk Management 2009, 5:819-831

Published Date: 25 September 2009

Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice

Cláudia Maria Vilas Freire, Antonio Luiz Pinho Ribeiro, Felipe Batista Lima Barbosa, et al

Vascular Health and Risk Management 2009, 5:811-817

Published Date: 24 September 2009

Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy

Jeetesh V Patel, Inessa Tracey, Elizabeth A Hughes, et al

Vascular Health and Risk Management 2009, 5:801-810

Published Date: 21 September 2009

Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk

Rakesh K Sharma, Vibhuti N Singh, Hanumanth K Reddy

Vascular Health and Risk Management 2009, 5:793-799

Published Date: 21 September 2009

Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation

Gerald V Naccarelli, Frank Peacock

Vascular Health and Risk Management 2009, 5:783-791

Published Date: 11 September 2009

Protein C preserves microcirculation in a model of neonatal septic shock

Doris Fischer, Marcel F Nold, Claudia A Nold-Petry, et al

Vascular Health and Risk Management 2009, 5:775-781

Published Date: 10 September 2009

Antiatherogenic effects of vitamin E: the search for the Holy Grail

Dimitrios Kirmizis, Dimitrios Chatzidimitriou

Vascular Health and Risk Management 2009, 5:767-774

Published Date: 10 September 2009

Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention

Jesús Millán, Xavier Pintó, Anna Muñoz, et al

Vascular Health and Risk Management 2009, 5:757-765

Published Date: 10 September 2009

HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men

Nikolaos Papanas, Paschalis Steiropoulos, Evangelia Nena, et al

Vascular Health and Risk Management 2009, 5:751-756

Published Date: 8 September 2009

Pattern of heart failure in a Nigerian teaching hospital

Arthur C Onwuchekwa, Godspower E Asekomeh

Vascular Health and Risk Management 2009, 5:745-750

Published Date: 7 September 2009

Metabolic syndrome and cardiovascular disease in South Asians

Danny Eapen, Girish L Kalra, Nadya Merchant, et al

Vascular Health and Risk Management 2009, 5:731-743

Published Date: 3 September 2009

Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study

Vivencio Barrios, Carlos Escobar, Alberto Calderon, et al

Vascular Health and Risk Management 2009, 5:723-729

Published Date: 27 August 2009

Cardiovascular disease in patients with chronic kidney disease

Julian Wright, Alastair Hutchison

Vascular Health and Risk Management 2009, 5:713-722

Published Date: 26 August 2009

Effects of efforts to intensify management on blood pressure control among patients with type 2 diabetes mellitus and hypertension: A pilot study

Ramona S DeJesus, Rajeev Chaudhry, Dorinda J Leutink, et al

Vascular Health and Risk Management 2009, 5:705-711

Published Date: 24 August 2009

Fibrinogen as a risk factor for premature myocardial infarction in Iranian patients: A case control study

Mohammad Shojaie, Morteza Pourahmad, Ahad Eshraghian, et al

Vascular Health and Risk Management 2009, 5:673-676

Published Date: 11 August 2009

RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension

Scott A Barman, Shu Zhu, Richard E White

Vascular Health and Risk Management 2009, 5:663-671

Published Date: 9 August 2009

Validation of reported physical activity for cholesterol control using two different physical activity instruments

Amy Z Fan, Sandra A Ham, Shravani Reddy Muppidi, et al

Vascular Health and Risk Management 2009, 5:649-661

Published Date: 6 August 2009

Dronedarone for atrial fibrillation: a new therapeutic agent

Pawan D Patel, Rohit Bhuriya, Dipal D Patel, et al

Vascular Health and Risk Management 2009, 5:635-642

Published Date: 5 August 2009

Should embolectomy be performed in late acute lower extremity arterial occlusions?

Hikmet Iyem, M Nesimi Eren

Vascular Health and Risk Management 2009, 5:621-626

Published Date: 31 July 2009

Irbesartan improves arterial compliance more than lisinopril

Khalid Ali, Chakravarthi Rajkumar, Francesco Fantin, Rebekah Schiff, Christopher J Bulpitt

Vascular Health and Risk Management 2009, 5:587-592

Published Date: 13 July 2009

Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension

Martin Thoenes, Jan-Christian Reil, Bobby Varkey Khan, Peter Bramlage, et al.

Vascular Health and Risk Management 2009, 5:577-585

Published Date: 13 July 2009

Prognostic stratification of acute pulmonary embolism: Focus on clinical aspects, imaging, and biomarkers

Luca Masotti, Marc Righini, Nicolas Vuilleumier, Fabio Antonelli, et al.

Vascular Health and Risk Management 2009, 5:567-575

Published Date: 2 July 2009

Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome

Marco Matteo Ciccone, Stefano Favale, Anish Bhuva, Pietro Scicchitano, et al.

Vascular Health and Risk Management 2009, 5:561-566

Published Date: 25 June 2009

The role of insulin detemir in overweight type 2 diabetes management

Yared N Demssie, Naveed Younis, Handrean Soran

Vascular Health and Risk Management 2009, 5:553-560

Published Date: 29 June 2009

Pleiotropic effects of statins in atrial fibrillation patients: the evidence

Hadi AR Hadi, Wael Al Mahmeed, Jassim Al Suwaidi, Samer Ellahham

Vascular Health and Risk Management 2009, 5:533-551

Published Date: 17 June 2009

Histopathologic changes of the radial artery wall secondary to transradial catheterization

Cezar S Staniloae, Kanika P Mody, Kintur Sanghvi, Catalin Mindrescu, et al.

Vascular Health and Risk Management 2009, 5:527-532

Published Date: 23 June 2009

Treatment of pediatric pulmonary hypertension

Amy Hawkins, Robert Tulloh

Vascular Health and Risk Management 2009, 5:509-524

Published Date: 3 June 2009

Reducing morbidity and mortality in high risk patients with statins

Vibhuti Singh, Prakash Deedwania

Vascular Health and Risk Management 2009, 5:495-507

Published Date: 5 June 2009

Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts

Nader Nouri-Majalan, Ehsan Fotouhi Ardakani, Khalil Forouzannia, Hosein Moshtaghian

Vascular Health and Risk Management 2009, 5:489-494

Published Date: 27 May 2009

Hematocrit and mean arterial blood pressure in pre- and postmenopause women

Beatriz Y Salazar Vázquez, Miguel A Salazar Vázquez, Marcos Intaglietta, Ulf de Faire, et al.

Vascular Health and Risk Management 2009, 5:483-488

Published Date: 25 May 2009

Inhaled iloprost for the control of pulmonary hypertension

Sabine Krug, Armin Sablotzki, Stefan Hammerschmidt, Hubert Wirtz, Hans-Juergen Seyfarth

Vascular Health and Risk Management 2009, 5:465-473

Published Date: 19 May 2009

The use of sibutramine in the management of obesity and related disorders: An update

Konstantinos Tziomalos, Gerasimos E Krassas, Themistoklis Tzotzas

Vascular Health and Risk Management 2009, 5:441-452

Published Date: 14 May 2009

Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials

Gianpaolo Reboldi, Giorgio Gentile, Fabio Angeli, Paolo Verdecchia

Vascular Health and Risk Management 2009, 5:411-427

Published Date: 8 May 2009

Safety and efficacy of alteplase in the treatment of acute ischemic stroke

Giuseppe Micieli, Simona Marcheselli, Piera Angela Tosi

Vascular Health and Risk Management 2009, 5:397-409

Published Date: 8 May 2009

Safety and efficacy of rosiglitazone in the elderly diabetic patient

Adie Viljoen, Alan Sinclair

Vascular Health and Risk Management 2009, 5:389-395

Published Date: 30 April 2009

Prevention of diabetes in hypertensive patients: Results and implications from the VALUE trial

Ming-Sheng Zhou, Ivonne Hernandez Schulman

Vascular Health and Risk Management 2009, 5:361-368

Published Date: 16 April 2009

Arterial stiffness, hypertension, and rational use of nebivolol

Enrico Agabiti-Rosei, Enzo Porteri, Damiano Rizzoni

Vascular Health and Risk Management 2009, 5:353-360

Published Date: 19 May 2009

Efficacy and safety of rosuvastatin in the management of dyslipidemia

Paolo Rubba, Gennaro Marotta, Marco Gentile

Vascular Health and Risk Management 2009, 5:343-352

Published Date: 7 April 2009

Prasugrel for the treatment of patients with acute coronary syndrome

Filippo Marzot, Vittorio Pengo

Vascular Health and Risk Management 2009, 5:321-324

Published Date: 6 April 2009

Prevention of atherosclerosis in patients living with HIV

Ferruccio De Lorenzo, Marta Boffito, Sophie Collot-Teixeira, Brian Gazzard, John L McGregor, Kevin Shotliff, Han Xiao

Vascular Health and Risk Management 2009, 5:287-300

Published Date: 26 March 2009

Corrigendum

Dove Medical Press Editorial

Vascular Health and Risk Management 2009, 5:273-274

Published Date: 18 March 2009

Candesartan cilexetil in the treatment of chronic heart failure

Jean-Philippe Baguet, Gilles Barone-Rochette, Yannick Neuder

Vascular Health and Risk Management 2009, 5:257-264

Published Date: 4 March 2009

Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction

Giovanni Melandri, Fabio Vagnarelli, Daniela Calabrese, Franco Semprini, Samuele Nanni, Angelo Branzi

Vascular Health and Risk Management 2009, 5:249-256

Published Date: 26 February 2009

The effect of angiotensin receptor blockers on C-reactive protein and other circulating inflammatory indices in man

Alessandra Del Fiorentino, Silvana Cianchetti, Alessandro Celi, Giulia Dell’Omo, Roberto Pedrinelli

Vascular Health and Risk Management 2009, 5:233-242

Published Date: 8 February 2009

Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review

Steve Fordan, Philip Raskin

Vascular Health and Risk Management 2009, 5:225-231

Published Date: 19 February 2009

Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis

R J M W Rennenberg, A G H Kessels, L J Schurgers, J M A van Engelshoven, P W de Leeuw, A A Kroon

Vascular Health and Risk Management 2009, 5:185-197

Published Date: 22 January 2009

Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study

JP Baguet, R Asmar, P Valensi, S Nisse-Durgeat, JM Mallion

Vascular Health and Risk Management 2009, 5:175-183

Published Date: 21 January 2009

The management of gestational diabetes

N Wah Cheung

Vascular Health and Risk Management 2009, 5:153-164

Published Date: 15 January 2009

Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study

Prasad Bichu, Ravi Nistala, Asma Khan, James R Sowers, Adam Whaley-Connell

Vascular Health and Risk Management 2009, 5:129-140

Published Date: 22 December 2008

Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia

Odd Erik Johansen, Pål Johan Vanberg, Bente Kvarv Kilhovd, Anders Palmstrøm Jørgensen

Vascular Health and Risk Management 2009, 5:121-128

Published Date: 18 December 2008

Diabetes mellitus: a prothrombotic state. Implications for outcomes after coronary revascularization

Clarissa Cola, Salvatore Brugaletta, Victoria Martín Yuste, Bieito Campos, Dominick J Angiolillo, Manel Sabaté

Vascular Health and Risk Management 2009, 5:101-119

Published Date: 11 January 2009

Effect of losartan on Doppler sonography indices in kidney transplant patients: A randomized clinical trial

Nader Nouri-Majalan, Reza Nafisi, Sarasadat Moghadasi-Mousavi

Vascular Health and Risk Management 2009, 5:97-100

Published Date: 10 December 2008

The independent relationship between triglycerides and coronary heart disease

Alan Morrison, John E Hokanson

Vascular Health and Risk Management 2009, 5:89-95

Published Date: 23 October 2008

Epidemiology of deep venous thrombosis during pregnancy and puerperium in Sudanese women

Asha A Gader, Abed Elrahium D Haggaz, Ishag Adam

Vascular Health and Risk Management 2009, 5:85-87

Published Date: 4 December 2008

Differential expression of Gs in a murine model of homocysteinemic heart failure

Thomas P Vacek, Utpal Sen, Neetu Tyagi, Jonathan C Vacek, Munish Kumar, et al

Vascular Health and Risk Management 2009, 5:79-84

Published Date: 4 December 2008

Arterial stiffness in insulin resistance: The role of nitric oxide and angiotensin II receptors

Divina G Brillante, Anthony J O’Sullivan, Laurence G Howes

Vascular Health and Risk Management 2009, 5:73-78

Published Date: 4 December 2008

Nonobese, exercising children diagnosed with dyslipidemia have normal C-reactive protein

Miguel Arturo Salazar, Vázquez, Beatriz Yadira Salazar, Vázquez, M Intaglietta, Pedro Cabrales

Vascular Health and Risk Management 2009, 5:65-72

Published Date: 30 September 2008

Current management of type B aortic dissection

T Paul Tran, Ali Khoynezhad

Vascular Health and Risk Management 2009, 5:53-63

Published Date: 10 October 2008

Risk factors associated with methamphetamine use and heart failure among Native Hawaiians and other Pacific Island peoples

Marjorie K Mau, Karynna Asao, Jimmy Efird, Erin Saito, Robert Ratner, et al

Vascular Health and Risk Management 2009, 5:45-52

Published Date: 7 December 2008

Relationship between blood pressure levels and adherence to medication in patients with chronic heart failure: How come?

Mahsa Mohammadi, Inger Ekman, Maria Schaufelberger

Vascular Health and Risk Management 2009, 5:13-19

Published Date: 2 December 2008

Alveolar dead space and capnographic variables before and after thrombolysis in patients with acute pulmonary embolism

Marcos Mello Moreira, Renato G G Terzi, Carlos Heitor N Carvalho, Antonio Francisco de Oliveira Neto, Mônica Corso Pereira, Ilma Aparecida Paschoal

Vascular Health and Risk Management 2009, 5:9-12

Published Date: 24 November 2008

Stress echocardiogaphy: A useful test for assessing cardiac risk in diabetes

Rajan Sharma, Denis Pellerin

Vascular Health and Risk Management 2009, 5:1-7

Published Date: 24 November 2008

Corrigendum

Dove Medical Press Editorial

Vascular Health and Risk Management 2008, 4:1481-1481

Published Date: 5 December 2008

Anabolic steroids, acute myocardial infarction and polycythemia: A case report and review of the literature

Kathleen Stergiopoulos, Joseph J Brennan, Robin Mathews, John F Setaro, Smadar Kort

Vascular Health and Risk Management 2008, 4:1475-1480

Published Date: 5 December 2008

Association of angiitis of central nervous system, cerebral amyloid angiopathy, and Alzheimer’s disease: Report of an autopsy case

Cédric Annweiler, Marc Paccalin, Gilles Berrut, Caroline Hommet, Christian Lavigne, et al

Vascular Health and Risk Management 2008, 4:1471-1474

Published Date: 5 December 2008

Sleep restriction increases white blood cells, mainly neutrophil count, in young healthy men: A pilot study

Karim Zouaoui Boudjeltia, Brice Faraut, Patricia Stenuit, Maria José Esposito, Michal Dyzma, et al

Vascular Health and Risk Management 2008, 4:1467-1470

Published Date: 5 December 2008

Characterization of the vasodilatory action of testosterone in the human pulmonary circulation

Alyson M Smith, Robert T Bennett, T Hugh Jones, Mike E Cowen, Kevin S Channer, Richard D Jones

Vascular Health and Risk Management 2008, 4:1459-1466

Published Date: 5 December 2008

Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes

Sandra Beer, François Feihl, Juan Ruiz, Irène Juhan-Vague, Marie-Françoise Aillaud, et al

Vascular Health and Risk Management 2008, 4:1449-1458

Published Date: 5 December 2008

Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia

Catalin Mindrescu, Rakesh P Gupta, Eileen V Hermance, Mary C DeVoe, Vikas R Soma, et al

Vascular Health and Risk Management 2008, 4:1439-1447

Published Date: 5 December 2008

Effect of statin therapy on serum activity of proteinases and cytokines in patients with abdominal aortic aneurysm

Bernd Muehling, Alexander Oberhuber, Hubert Schelzig, Gisela Bischoff, Nikolaus Marx, et al

Vascular Health and Risk Management 2008, 4:1433-1437

Published Date: 5 December 2008

Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis

Naheed Aryaeian, Farhad Shahram, Mahmoud Djalali, Mohammad R Eshragian, Abolghasem Djazayeri, et al

Vascular Health and Risk Management 2008, 4:1423-1432

Published Date: 5 December 2008

The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions

Oyku Gulmez, Ilyas Atar, Bülent Ozin, Mehmet Emin Korkmaz, Asli Atar, et al

Vascular Health and Risk Management 2008, 4:1417-1422

Published Date: 5 December 2008

Dual factor pulse pressure: body mass index and outcome in type 2 diabetic subjects on maintenance  hemodialysis. A longitudinal study 2003–2006

Lydia Foucan, Kheira Hue, Jocelyn Inamo, Jacqueline Deloumeaux, Anne Blanchet-Deverly, et al

Vascular Health and Risk Management 2008, 4:1401-1406

Published Date: 5 December 2008

Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction

William H Frishman, Linda S Henderson, Mary Ann Lukas

Vascular Health and Risk Management 2008, 4:1387-1400

Published Date: 5 December 2008

Emergence of new oral antithrombotics: a critical appraisal of their clinical potential

Michael Rud Lassen, Volker Laux

Vascular Health and Risk Management 2008, 4:1373-1386

Published Date: 5 December 2008

Arterial pulse wave velocity, inflammatory markers, pathological GH and IGF states, cardiovascular and cerebrovascular disease

Michael R Graham, Peter Evans, Bruce Davies, Julien S Baker

Vascular Health and Risk Management 2008, 4:1361-1371

Published Date: 5 December 2008

Vildagliptin: a new oral treatment for type 2 diabetes mellitus

Chantal Mathieu, Evy Degrande

Vascular Health and Risk Management 2008, 4:1349-1360

Published Date: 5 December 2008

Thrombosis in the critically ill neonate: incidence, diagnosis, and management

Alex Veldman, Marcel F Nold, Ina Michel-Behnke

Vascular Health and Risk Management 2008, 4:1337-1348

Published Date: 5 December 2008

Mechanisms of endothelial dysfunction in obstructive sleep apnea

Amy Atkeson, Sanja Jelic

Vascular Health and Risk Management 2008, 4:1327-1335

Published Date: 5 December 2008

Pathophysiology of placentation abnormalities in pregnancy-induced hypertension

Mitsuko Furuya, Junji Ishida, Ichiro Aoki, Akiyoshi Fukamizu

Vascular Health and Risk Management 2008, 4:1301-1313

Published Date: 5 December 2008

Role of TGF-β on cardiac structural and electrical remodeling

Roberto Ramos-Mondragón, Carlos A Galindo, Guillermo Avila

Vascular Health and Risk Management 2008, 4:1289-1300

Published Date: 5 December 2008

Beta-glucans in the treatment of diabetes and associated cardiovascular risks

Jiezhong Chen, Kenneth Raymond

Vascular Health and Risk Management 2008, 4:1265-1272

Published Date: 5 December 2008

Managing hypercholesterolemia and its correlation with carotid plaque morphology in patients undergoing carotid endarterectomy

Kittipan Rerkasem, Patrick J Gallagher, Robert F Grimble, Philip C Calder, Clifford P Shearman

Vascular Health and Risk Management 2008, 4:1259-1264

Published Date: 5 December 2008

Long-acting nifedipine in the management of the hypertensive patient

Morgan E Snider, Donald S Nuzum, Angie Veverka

Vascular Health and Risk Management 2008, 4:1249-1257

Published Date: 5 December 2008

Safety and efficacy of cilostazol in the management of intermittent claudication

Yung-Wei Chi, Carl J Lavie, Richard V Milani, Christopher J White

Vascular Health and Risk Management 2008, 4:1197-1203

Published Date: 5 December 2008

Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes

Floris Alexander van de Laar

Vascular Health and Risk Management 2008, 4:1189-1195

Published Date: 5 December 2008

Peripheral artery disease: potential role of ACE-inhibitor therapy

Giuseppe Coppola, Giuseppe Romano, Egle Corrado, Rosa Maria Grisanti, Salvatore Novo

Vascular Health and Risk Management 2008, 4:1179-1187

Published Date: 5 December 2008

Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes

Marc K Israel, Eva Istvan, Michelle A Baron

Vascular Health and Risk Management 2008, 4:1167-1178

Published Date: 5 December 2008

Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine

Menno T Pruijm, Marc P Maillard, Michel Burnier

Vascular Health and Risk Management 2008, 4:1159-1166

Published Date: 5 December 2008

Update on the use of Trandolapril in the management of cardiovascular disorders

Ariel Diaz, Anique Ducharme

Vascular Health and Risk Management 2008, 4:1147-1158

Published Date: 5 December 2008

ISVH – October Newsletter

Prof. Roland Asmar, David Oldfield

Vascular Health and Risk Management 2008, 4:1145-1146

Published Date: 10 October 2008

Aberrant positioning of a central venous dialysis catheter to reveal a left-sided partial anomalous pulmonary venous connection

Manohar R Chintu, Shammikumar Chinnappa, Sunil Bhandari

Vascular Health and Risk Management 2008, 4:1141-1143

Published Date: 10 October 2008

Severe macular edema induced by pioglitazone in a patient with diabetic retinopathy: a case study

Toshiyuki Oshitari, Noriko Asaumi, Masaru Watanabe, Ken Kumagai, Yoshinori Mitamura

Vascular Health and Risk Management 2008, 4:1137-1140

Published Date: 10 October 2008

Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience

Glen J Pearson, Kari L Olson, Nicole E Panich, Sumit R Majumdar, Ross T Tsuyuki, et al

Vascular Health and Risk Management 2008, 4:1127-1135

Published Date: 10 October 2008

Validation of the Oregon Scientific BPU 330 for self-monitoring of blood pressure according to the International Protocol

Li Li, XinYu Zhang, ChunHong Yan, QingXiang Liang

Vascular Health and Risk Management 2008, 4:1121-1125

Published Date: 10 October 2008

Under- and overreporting of energy in a group of candidates for CABG surgery and its association with some anthropometric and sociodemographic factors, Tehran, Iran

Bahareh Amirkalali, Mehdi Najafi, Asal Ataie-Jafari, Saeed Hosseini, Ramin Heshmat

Vascular Health and Risk Management 2008, 4:1115-1120

Published Date: 10 October 2008

Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension

Anne M Keogh, Andrew Jabbour, Christopher S Hayward, Peter S Macdonald

Vascular Health and Risk Management 2008, 4:1111-1113

Published Date: 10 October 2008

Compliance of the aorta in two diseases affecting vascular elasticity, familial hypercholesterolemia and diabetes: a MRI study

Sami Soljanlahti, Taina Autti, Laura Hyttinen, Alpo F Vuorio, Pekka Keto, Kirsi Lauerma

Vascular Health and Risk Management 2008, 4:1103-1109

Published Date: 10 October 2008

The development of abdominal aortic aneurysms in mice is enhanced by benzo(a)pyrene

Yong Zhang, Kenneth S Ramos

Vascular Health and Risk Management 2008, 4:1095-1102

Published Date: 10 October 2008

Frequency of secondary dyslipidemia in obese children

Ulrike Korsten-Reck, Katrin Kromeyer-Hauschild, Katrin Korsten, Manfred W Baumstark, Hans-H Dickhuth, Aloys Berg

Vascular Health and Risk Management 2008, 4:1089-1094

Published Date: 10 October 2008

Postpartum thromboembolism: Severe events might be preventable using a new risk score model

Pelle G Lindqvist, Jelena Torsson, Åsa Almqvist, Ola Björgell

Vascular Health and Risk Management 2008, 4:1081-1087

Published Date: 10 October 2008

ST segment depression in hypertensive patients: A comparison of exercise test versus Holter ECG

Sakir Uen, Rolf Fimmers, Burkhard Weisser, Osman Balta, Georg Nickenig, Thomas Mengden

Vascular Health and Risk Management 2008, 4:1073-1080

Published Date: 10 October 2008

Single photon emission computed tomography: An alternative imaging modality in left ventricular evaluation

Hulya Yalçin, Sofiane Maza, Fatih Yalçin

Vascular Health and Risk Management 2008, 4:1069-1072

Published Date: 10 October 2008

Arterial pulmonary hypertension in noncardiac intensive care unit

Mykola V Tsapenko, Arseniy V Tsapenko, Thomas BO Comfere, Girish K Mour, Sunil V Mankad, Ognjen Gajic

Vascular Health and Risk Management 2008, 4:1043-1060

Published Date: 10 October 2008

Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: Current understandings and future research priorities

Todd C Rideout, Scott V Harding, Peter JH Jones, Ming Z Fan

Vascular Health and Risk Management 2008, 4:1023-1033

Published Date: 10 October 2008

Effects of study design and trends for EVAR versus OSR

Robert Hopkins, James Bowen, Kaitryn Campbell, Gord Blackhouse, Guy De Rose, et al

Vascular Health and Risk Management 2008, 4:1011-1022

Published Date: 10 October 2008

Targeting mulitple dyslipidemias with fixed combinations – focus on extended release niacin and simvastatin

Anbu Pandian, Anjali Arora, Laurence S Sperling, Bobby V Khan

Vascular Health and Risk Management 2008, 4:1001-1009

Published Date: 10 October 2008

Clinical use of parnaparin in major and minor orthopedic sugery: a review

Stefano Bugamelli, Elena Zangheri, Milena Montebugnoli, Lucia Guerra

Vascular Health and Risk Management 2008, 4:983-990

Published Date: 10 October 2008

The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction

Paolo Verdecchia, Fabio Angeli, Giovanni Mazzotta, Giorgio Gentile, Gianpaolo Reboldi

Vascular Health and Risk Management 2008, 4:971-981

Published Date: 10 October 2008

Early detection and efficient therapy of cardiac angiosarcoma due to routine transesophageal echocardiography after cerebrovascular stroke

Dirk Vogelgesang, Johannes B Dahm, Holm Großmann, Andre Hippe, Astrid Hummel, et al

Vascular Health and Risk Management 2008, 4:937-941

Published Date: 8 August 2008

Subtemporal approach to basilar tip aneurysm with division of posterior communicating artery: Technical note

Shunsuke Kakino, Kuniaki Ogasawara, Yoshitaka Kubo, Hideaki Nishimoto, Akira Ogawa

Vascular Health and Risk Management 2008, 4:931-935

Published Date: 8 August 2008

Aorta of young and middle-aged heterozygous familial hypercholesterolemia patients shows no functional or morphological impairment assessed by MRI

Sami Soljanlahti, Taina Autti, Alpo F Vuorio, Pekka Keto, Hannu Turtola, Kirsi Lauerma

Vascular Health and Risk Management 2008, 4:923-929

Published Date: 8 August 2008

Blood pressure reduction due to hemoglobin glycosylation in type 2 diabetic patients

Pedro Cabrales, Miguel A Salazar Vázquez, Beatriz Y Salazar Vázquez, Martha Rodríguez-Morán, Marcos Intaglietta, Fernando Guerrero-Romero

Vascular Health and Risk Management 2008, 4:917-922

Published Date: 8 August 2008

Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers

André C Schmidt, Burkhard Flick, Elke Jahn, Peter Bramlage

Vascular Health and Risk Management 2008, 4:905-915

Published Date: 8 August 2008

Comparative evaluation of 64-slice CT angiography and digital subtraction angiography in assessing the cervicocranial vasculature

Randolf Klingebiel, Max Kentenich, Hans-Christian Bauknecht, Florian Masuhr, Eberhard Siebert, et al

Vascular Health and Risk Management 2008, 4:901-907

Published Date: 8 August 2008

Determination of RBC membrane and serum lipid composition in trinidadian type II diabetics with and without nephropathy

B Shivananda Nayak, Vishi Y Beharry, Shivani Armoogam, Melinda Nancoo, Kevin Ramadhin, et al

Vascular Health and Risk Management 2008, 4:893-899

Published Date: 8 August 2008

Is continuous insulin treatment safe in aneurysmal subarachnoid hemorrhage?

Florian Schlenk, Asita S Sarrafzadeh

Vascular Health and Risk Management 2008, 4:885-891

Published Date: 8 August 2008

Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: Comparison with high cardiovascular risk population

Alberto Palazzuoli, Maddalena Gallotta, Giuseppe Guerrieri, Ilaria Quatrini, Beatrice Franci, et al

Vascular Health and Risk Management 2008, 4:877-883

Published Date: 8 August 2008

Relationship between serum albumin and pulse wave velocity in patients on continuous ambulatory peritoneal dialysis

Li-Tao Cheng, Li-Jun Tang, Hui-Min Chen, Wen Tang, Tao Wang

Vascular Health and Risk Management 2008, 4:871-876

Published Date: 8 August 2008

The interleukin-6 –174 G/C promoter polymorphism and arterial stiffness; the Rotterdam Study

Mark PS Sie, Francesco US Mattace-Raso, André G Uitterlinden, Pascal P Arp, Albert Hofman, et al

Vascular Health and Risk Management 2008, 4:863-869

Published Date: 8 August 2008

Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril

Vivencio Barrios, Carlos Escobar, Rocio Echarri

Vascular Health and Risk Management 2008, 4:847-853

Published Date: 8 August 2008

Detection of metabolic syndrome features among childhood cancer survivors: A target to prevent disease

Adriana Aparecida Siviero-Miachon, Angela Maria Spinola-Castro, Gil Guerra-Junior

Vascular Health and Risk Management 2008, 4:825-836

Published Date: 8 August 2008

Utility of ranolazine in chronic stable angina patients

Pawan D Patel, Rohit R Arora

Vascular Health and Risk Management 2008, 4:819-824

Published Date: 8 August 2008

TNF-α-mediated inflammation in cerebral aneurysms: A potential link to growth and rupture

Thottala Jayaraman, Andrew Paget, Yang Sam Shin, Xiaguai Li, Jillian Mayer, et al

Vascular Health and Risk Management 2008, 4:805-817

Published Date: 8 August 2008

The renin–angiotensin system and diabetes: An update

Antônio Ribeiro-Oliveira Jr, Anelise Impeliziere Nogueira, Regina Maria Pereira, Walkiria Wingester Vilas Boas, Robson Augusto Souza dos Santos, Ana Cristina Simões e Silva

Vascular Health and Risk Management 2008, 4:787-803

Published Date: 8 August 2008

Urotensin II in cardiovascular regulation

Fraser D Russell

Vascular Health and Risk Management 2008, 4:775-785

Published Date: 8 August 2008

Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes

Bernd Richter, Elizabeth Bandeira-Echtler, Karla Bergerhoff, Christian Lerch

Vascular Health and Risk Management 2008, 4:753-768

Published Date: 8 August 2008

Erratum

Erhardt L, Moller R, Puig JC. 2007

Vascular Health and Risk Management 2008, 4:741-741

Published Date: 6 June 2008

Diagnosis with ECG-gated MDCT of floating thrombus in aortic arch in a patient with type-A dissection

Domenico Lumia, Gianpaolo Carrafiello, Domenico Laganà, Andrea Musazzi, Andrea Giorgianni, et al

Vascular Health and Risk Management 2008, 4:735-739

Published Date: 6 June 2008

Intertester reliability of brachial artery flow-mediated vasodilation using upper and lower arm occlusion in healthy subjects

Ludmila M Cosio-Lima, Richard Seip, Paul D Thompson, Marie A Lagasse, Tabitha H Hodges

Vascular Health and Risk Management 2008, 4:731-734

Published Date: 6 June 2008

Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: Implication in the pathogenesis of Alzheimer’s disease

Gjumrakch Aliev, Eldar Gasimov, Mark E Obrenovich, Kathryn Fischbach, Justin C Shenk, et al

Vascular Health and Risk Management 2008, 4:721-730

Published Date: 6 June 2008

Early seizures in patients with acute stroke: Frequency, predictive factors, and effect on clinical outcome

Andrea Alberti, Maurizio Paciaroni, Valeria Caso, Michele Venti, Francesco Palmerini, Giancarlo Agnelli

Vascular Health and Risk Management 2008, 4:715-720

Published Date: 6 June 2008

Estrogen-induced improvement in coronary flow responses during atrial pacing in relation to endothelin-1 levels in postmenopausal women without coronary disease

Ioannis Kallikazaros, Costas Tsioufis, Panagiotis Zambaras, Ioannis Skiadas, Marina Toutouza, et al

Vascular Health and Risk Management 2008, 4:705-714

Published Date: 6 June 2008

Cigarette smoking leads to reduced relaxant responses of the cutaneous microcirculation

Marie-Louise Edvinsson, Sven E Andersson, Cang-Bao Xu, Lars Edvinsson

Vascular Health and Risk Management 2008, 4:699-704

Published Date: 6 June 2008

Five-year incidence of type 2 diabetes mellitus among cardiovascular disease-free Greek adults: Findings from the ATTICA study

Demosthenes B Panagiotakos, Christos Pitsavos, Yannis Skoumas, Yannis Lentzas, Christodoulos Stefanadis

Vascular Health and Risk Management 2008, 4:691-698

Published Date: 6 June 2008

The influence of polymorbidity, revascularization, and wound therapy on the healing of arterial ulceration

Joerg Tautenhahn, Ralf Lobmann, Brigitte Koenig, Zuhir Halloul, Hans Lippert, Thomas Buerger

Vascular Health and Risk Management 2008, 4:683-689

Published Date: 6 June 2008

Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen

Bimal V Patel, R Scott Leslie, Patrick Thiebaud, Michael B Nichol, Simon SK Tang, et al

Vascular Health and Risk Management 2008, 4:673-681

Published Date: 6 June 2008

Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study

Claudio Borghi, Arrigo FG Cicero, Ettore Ambrosioni

Vascular Health and Risk Management 2008, 4:665-671

Published Date: 6 June 2008

Measurement of endothelial function and its clinical utility for cardiovascular risk

Mo Al-Qaisi, Rajesh K Kharbanda, Tarun K Mittal, Ann E Donald

Vascular Health and Risk Management 2008, 4:647-652

Published Date: 6 June 2008

Antiplatelet drugs in cardiological practice: Established strategies and new developments

Florian Krötz, Hae-Young Sohn, Volker Klauss

Vascular Health and Risk Management 2008, 4:637-645

Published Date: 6 June 2008

Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation

Luca Masotti, Patrick Ray, Marc Righini, Gregoire Le Gal, Fabio Antonelli, et al

Vascular Health and Risk Management 2008, 4:629-636

Published Date: 6 June 2008

Perioperative hypertension management

Joseph Varon, Paul E Marik

Vascular Health and Risk Management 2008, 4:615-627

Published Date: 6 June 2008

Cardiovascular co-morbidity in rheumatic diseases

Carl Turesson, Lennart TH Jacobsson, Eric L Matteson

Vascular Health and Risk Management 2008, 4:605-614

Published Date: 6 June 2008

Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease

Kjeld Hermansen, Lene Sundahl Mortensen, Marie-Louise Hermansen

Vascular Health and Risk Management 2008, 4:561-574

Published Date: 6 June 2008

Drug-eluting stents in the management of peripheral arterial disease

Marc Bosiers, Catherine Cagiannos, Koen Deloose, Jürgen Verbist, Patrick Peeters

Vascular Health and Risk Management 2008, 4:553-559

Published Date: 6 June 2008

Early vascular aging (EVA): consequences and prevention

Peter M Nilsson

Vascular Health and Risk Management 2008, 4:547-552

Published Date: 6 June 2008

Systematic review of implementation strategies for risk tables in the prevention of cardiovascular diseases

Ben van Steenkiste, Richard Grol, Trudy van der Weijden

Vascular Health and Risk Management 2008, 4:535-545

Published Date: 6 June 2008

Relative safety profiles of high dose statin regimens

Carlos Escobar, Rocio Echarri, Vivencio Barrios

Vascular Health and Risk Management 2008, 4:525-533

Published Date: 6 June 2008

Relaxin as a natural agent for vascular health

Daniele Bani

Vascular Health and Risk Management 2008, 4:515-524

Published Date: 6 June 2008

Treprostinil for pulmonary hypertension

Nika Skoro-Sajer, Irene Lang, Robert Naeije

Vascular Health and Risk Management 2008, 4:507-513

Published Date: 6 June 2008

Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet

Serge Halimi, Anja Schweizer, Biljana Minic, James Foley, Sylvie Dejager

Vascular Health and Risk Management 2008, 4:481-492

Published Date: 6 June 2008

A young man with acute dilated cardiomyopathy associated with methylphenidate

Tor-Bjarne Nymark, A Hovland, H Bjørnstad, E W Nielsen

Vascular Health and Risk Management 2008, 4:477-479

Published Date: 11 April 2008

Effect of ramipril on renal function in patients with intermittent claudication

Simon D Hobbs, Martin W Claridge, Antonius BM Wilmink, Donald J Adam, Mark E Thomas, Andrew W Bradbury

Vascular Health and Risk Management 2008, 4:471-475

Published Date: 11 April 2008

Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy

Guliz Kozdag, Ercument Ciftci, Dilek Ural, Tayfun Sahin, Macit Selekler, et al

Vascular Health and Risk Management 2008, 4:463-469

Published Date: 11 April 2008

Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?

Evelyn O Talbott, Jeanne Zborowski, Judy Rager, Juley R Stragand

Vascular Health and Risk Management 2008, 4:453-462

Published Date: 11 April 2008

Time-dependent alterations in serum NO concentration after oral administration of L-arginine, L-NAME, and allopurinol in intestinal ischemia/reperfusion

Amalia E Yanni, Eleutherios Margaritis, Nikolaos Liarakos, Alkisti Pantopoulou, Maria Poulakou, et al

Vascular Health and Risk Management 2008, 4:437-441

Published Date: 11 April 2008

Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: A case-cohort study and meta-analyses

Mohammad Hadi Zafarmand, Yvonne T van der Schouw, Diederick E Grobbee, Peter W de Leeuw, Michiel L Bots

Vascular Health and Risk Management 2008, 4:427-436

Published Date: 11 April 2008

Kennedy space center cardiovascular disease risk reduction program evaluation

Kristine S Calderon, Charles Smallwood, David A Tipton

Vascular Health and Risk Management 2008, 4:421-426

Published Date: 11 April 2008

Japanese study to organize proper lifestyle modifications for metabolic syndrome (J-STOP-MetS): Design and method

Masanori Munakata, Hiroki Honma, Mitugu Akasi, Takaharu Araki, Takahiko Kawamura, et al

Vascular Health and Risk Management 2008, 4:415-420

Published Date: 11 April 2008

Preferred drug lists: Potential impact on healthcare economics

Kimberly Ovsag, Sabrina Hydery, Shaker A Mousa

Vascular Health and Risk Management 2008, 4:403-413

Published Date: 11 April 2008

Risk factors for vascular dementia: Hypotension as a key point

Rita Moretti, Paola Torre, Rodolfo M Antonello, Davide Manganaro, Cristina Vilotti, Gilberto Pizzolato

Vascular Health and Risk Management 2008, 4:395-402

Published Date: 11 April 2008

Vascular risk factors, cognitve decline, and dementia

E Duron, Olivier Hanon

Vascular Health and Risk Management 2008, 4:363-381

Published Date: 11 April 2008

Clinical efficacy and safety of statins in managing cardiovascular risk

Navin K Kapur, Kiran Musunuru

Vascular Health and Risk Management 2008, 4:341-353

Published Date: 11 April 2008

Regadenoson in the detection of coronary artery disease

Christiane Buhr, Mario Gössl, Raimund Erbel, Holger Eggebrecht

Vascular Health and Risk Management 2008, 4:337-340

Published Date: 11 April 2008

Orlistat in the prevention of diabetes in the obese patient

Marcio C Mancini, Alfredo Halpern

Vascular Health and Risk Management 2008, 4:325-336

Published Date: 11 April 2008

Expert review on coronary calcium

Matthew J Budoff, Khawar M Gul

Vascular Health and Risk Management 2008, 4:315-324

Published Date: 11 April 2008

Early detection and management of the high-risk patient with elevated blood pressure

Cristina Sierra, Alejandro de la Sierra

Vascular Health and Risk Management 2008, 4:289-296

Published Date: 11 April 2008

Combination therapy in cholesterol reduction: focus on ezetimibe and statins

Liliana Grigore, Giuseppe Danilo Norata, Alberico L Catapano

Vascular Health and Risk Management 2008, 4:267-278

Published Date: 11 April 2008

Kaposiform hemangioendothelioma with distant lymphangiomatosis without an association to Kasabach-Merritt-Syndrome in a female adult!

Claudia S Vetter-Kauczok, Philipp Ströbel, Eva B Bröcker, Jürgen C Becker

Vascular Health and Risk Management 2008, 4:263-266

Published Date: 8 February 2008

A hazardous finding of a rare anomalous left main coronary artery in a patient with a secundum atrial septal defect

Michael Emery, Waqas Ghumman, Shawn Teague, Jo Mahenthiran

Vascular Health and Risk Management 2008, 4:259-262

Published Date: 8 February 2008

Dissection of the ascending thoracic aorta as a complication of percutaneous coronary intervention

Cihangir Uyan, Huseyin Arinc, Huseyin Gunduz, Ramazan Akdemir

Vascular Health and Risk Management 2008, 4:253-257

Published Date: 8 February 2008

Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy

B Shivananda Nayak, Heidi Duncan, Sunita Lalloo, Kevin Maraj, Vani Matmungal, et al

Vascular Health and Risk Management 2008, 4:243-247

Published Date: 8 February 2008

Lipid-lowering effects of methanolic extract of Vernonia amygdalina leaves in rats fed on high cholesterol diet

Oluwatosin A Adaramoye, Olajumoke Akintayo, Jonah Achem, Michael A Fafunso

Vascular Health and Risk Management 2008, 4:235-241

Published Date: 8 February 2008

Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy

Giorgio L Colombo, Mauro Caruggi, Chiara Ottolini, Aldo P Maggioni

Vascular Health and Risk Management 2008, 4:223-234

Published Date: 8 February 2008

Effect of short-term lycopene supplementation and postprandial dyslipidemia on plasma antioxidants and biomarkers of endothelial health in young, healthy individuals

Steven G Denniss, Thomas D Haffner, Jeffrey T Kroetsch, Sara R Davidson, James WE Rush, Richard L Hughson

Vascular Health and Risk Management 2008, 4:213-222

Published Date: 8 February 2008

Application of cardiovascular disease risk prediction models and the relevance of novel biomarkers to risk stratification in Asian Indians

S Kanjilal, VS Rao, M Mukherjee, BK Natesha1, KS Renuka, et al

Vascular Health and Risk Management 2008, 4:199-211

Published Date: 8 February 2008

Prevalence and component analysis of metabolic syndrome: An Indian atherosclerosis research study perspective

Saikat Kanjilal, Jayashree Shanker, Veena S Rao, Natesha B Khadrinarasimhaih, Manjari Mukherjee, et al

Vascular Health and Risk Management 2008, 4:189-197

Published Date: 8 February 2008

Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population

Deirdre F Waterhouse, Ronan A Cahill, Frances Sheehan, CJ McCreery

Vascular Health and Risk Management 2008, 4:177-187

Published Date: 8 February 2008

Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 study

Cihangir Uyan, Huseyin Arinc, Huseyin Gunduz, Ramazan Akdemir

Vascular Health and Risk Management 2008, 4:173-176

Published Date: 8 February 2008

Therapeutic implications of transesophageal echocardiography after transthoracic echocardiography on acute stroke patients

Tiago Tribolet de Abreu, Sonia Mateus, Cecilia Carreteiro, Jose Correia

Vascular Health and Risk Management 2008, 4:167-172

Published Date: 8 February 2008

Adherence treatment factors in hypertensive African American women

Marie N Fongwa, Lorraines S Evangelista, Ron D Hays, David S Martins, David Elashoff, et al

Vascular Health and Risk Management 2008, 4:157-166

Published Date: 8 February 2008

Update on the use of fibrates: focus on bezafibrate

Ilan Goldenberg, Michal Benderly, Uri Goldbourt

Vascular Health and Risk Management 2008, 4:131-141

Published Date: 8 February 2008

Heart failure in sub-Saharan Africa: A literature review with emphasis on individuals with diabetes

Andre Pascal Kengne, Anastase Dzudie, Eugene Sobngwi

Vascular Health and Risk Management 2008, 4:123-130

Published Date: 8 February 2008

Endoplasmic reticulum stress and diabetic retinopathy

Toshiyuki Oshitari, Natsuyo Hata, Shuichi Yamamoto

Vascular Health and Risk Management 2008, 4:115-122

Published Date: 8 February 2008

Chronic heart failure in Japan: Implications of the CHART studies

Nobuyuki Shiba, Hiroaki Shimokawa

Vascular Health and Risk Management 2008, 4:103-113

Published Date: 8 February 2008

Diagnosis and surgical approach of popliteal artery entrapment syndrome: a retrospective study

Stavros Gourgiotis, John Aggelakas, Nikolaos Salemis, Charalabos Elias, Charalabos Georgiou

Vascular Health and Risk Management 2008, 4:83-88

Published Date: 8 February 2008

Perioperative use of statins in noncardiac surgery

YC Chan, SW Cheng, MG Irwin

Vascular Health and Risk Management 2008, 4:75-81

Published Date: 8 February 2008

Current role of endovascular therapy in Marfan patients with previous aortic surgery

Ibrahim Akin, Stephan Kische, Tim C Rehders, Tushar Chatterjee, Henrik Schneider, et al

Vascular Health and Risk Management 2008, 4:59-66

Published Date: 8 February 2008

High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease

Navin K Kapur, Dominique Ashen, Roger S Blumenthal

Vascular Health and Risk Management 2008, 4:39-57

Published Date: 8 February 2008

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)

Imad Sheiban, Gianluca Villata, Mario Bollati, Dario Sillano, Marzia Lotrionte, Giuseppe Biondi-Zoccai

Vascular Health and Risk Management 2008, 4:31-38

Published Date: 8 February 2008

Carvedilol in hypertension treatment

Panagiotis C Stafylas, Pantelis A Sarafidis

Vascular Health and Risk Management 2008, 4:23-30

Published Date: 8 February 2008

Androgen therapy and atherosclerotic cardiovascular disease

K-CY McGrath, LS McRobb, AK Heather

Vascular Health and Risk Management 2008, 4:11-21

Published Date: 8 February 2008

Gadofosveset-enhanced magnetic resonance angiography

Mathias Goyen

Vascular Health and Risk Management 2008, 4:1-9

Published Date: 8 February 2008

Smoking cessation: a European perspective

Eva Králíková (Guest Editor)

Institute of Hygiene and Epidemiology, and Tobacco Dependence Treatment Centre of the 3rd Medical Department, First Faculty of Medicine, Charles University and the General University Hospital of Prague

Vascular Health and Risk Management 2008, 4:1-23

Published Date: 24 July 2008

Isolated periaortitis: Clinical and imaging characteristics

Abdel-Rauf Zeina, Slobodin Gleb, Jochanan E Naschitz, Zeev Loberman, Elisha Barmeir

Vascular Health and Risk Management 2007, 3:1083-1086

Published Date: 15 January 2008

Acute management of poor condition subarachnoid hemorrhage patients

Archavlis Eleftherios, Carvi y Nievas Mario Nazareno

Vascular Health and Risk Management 2007, 3:1075-1082

Published Date: 15 January 2008

Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity

Barbara Ludolph, Wilhelm Bloch, Malte Kelm, Rainer Schulz, Petra Kleinbongard

Vascular Health and Risk Management 2007, 3:1069-1073

Published Date: 15 January 2008

Adult nontwin sib concordance rates for type 2 diabetes, hypertension and metabolic syndrome among Asian Indians: The Indian Atherosclerosis Research Study

Jayashree Shanker, Saikat Kanjilal, Veena S Rao, Ganapathy Perumal, Natesha B Khadrinarasimhiah, et al

Vascular Health and Risk Management 2007, 3:1063-1068

Published Date: 15 January 2008

Pathogenic role of cardiac mast cell activation/degranulation, TNF-α, and cell death in acute drug-related fatalities

Nasrin Perskvist, Carl Söderberg, Marianne van Hage, Erik Edston

Vascular Health and Risk Management 2007, 3:1053-1062

Published Date: 15 January 2008

Secular trends in lipid-lowering treatment and lipid levels after a first acute myocardial infarction

Lena Björck, Catharina Welin, Annika Rosengren

Vascular Health and Risk Management 2007, 3:1045-1051

Published Date: 15 January 2008

Higher persistence with valsartan compared with enalapril in daily practice

Satu J Siiskonen, Nancy S Breekveldt-Postma, Gábor Vincze, Zeba M Khan, Joëlle A Erkens, et al

Vascular Health and Risk Management 2007, 3:1039-1044

Published Date: 15 January 2008

Influence of albuminuria and glomerular filtration rate on blood pressure response to antihypertensive drug therapy

John M Flack, Karl Duncan, Suzanne E Ohmit, Ruth Quah, Xuefeng Liu, et al

Vascular Health and Risk Management 2007, 3:1029-1037

Published Date: 15 January 2008

Rheumatic heart disease: 15 years of clinical and immunological follow-up

Roney O Sampaio, Kellen C Fae, Lea MF Demarchi, Pablo MA Pomerantzeff, Vera D Aiello, et al

Vascular Health and Risk Management 2007, 3:1007-1017

Published Date: 15 January 2008

A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice

Maddalena Veronesi, Arrigo FG Cicero, Maria Grazia Prandin, Ada Dormi, Eugenio Cosentino, et al

Vascular Health and Risk Management 2007, 3:999-1005

Published Date: 15 January 2008

Reduction of C-reactive protein and the use of anti-hypertensives

Carmine Savoia, Ernesto L Schiffrin

Vascular Health and Risk Management 2007, 3:975-983

Published Date: 15 January 2008

The applicability of home blood pressure measurement in clinical practice: A review of literature

Willem J Verberk, Abraham A Kroon, Heidi A Jongen-Vancraybex, Peter W de Leeuw

Vascular Health and Risk Management 2007, 3:959-966

Published Date: 15 January 2008

Inhaled insulin for controlling blood glucose in patients with diabetes

Bernard L Silverman, Christopher J Barnes, Barbara N Campaigne, Douglas B Muchmore

Vascular Health and Risk Management 2007, 3:947-958

Published Date: 15 January 2008

Regulation of the renin–angiotensin system in coronary atherosclerosis: A review of the literature

Ramadan A Hammoud, Christopher S Vaccari, Sameer H Nagamia, Bobby V Khan

Vascular Health and Risk Management 2007, 3:937-945

Published Date: 15 January 2008

Review of biphasic insulin aspart in the treatment of type 1 and 2 diabetes

Nazia Raja-Khan, Sarah S Warehime, Robert A Gabbay

Vascular Health and Risk Management 2007, 3:919-935

Published Date: 15 January 2008

Clinical trial update: focus on the ONTARGET study

David Fitchett

Vascular Health and Risk Management 2007, 3:901-908

Published Date: 15 January 2008

Review of bosentan in the management of pulmonary arterial hypertension

Eli Gabbay, John Fraser, Keith McNeil

Vascular Health and Risk Management 2007, 3:887-900

Published Date: 15 January 2008

Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date

Antonio Gaddi, AFG Cicero, FO Odoo, A Poli A, R Paoletti

Vascular Health and Risk Management 2007, 3:877-886

Published Date: 15 January 2008

Endothelial dysfunction in diabetes mellitus

Hadi AR Hadi, Jassim Al Suwaidi

Vascular Health and Risk Management 2007, 3:853-876

Published Date: 15 January 2008

Review of duloxetine in the management of diabetic peripheral neuropathic pain

Timothy Smith, Robert A Nicholson

Vascular Health and Risk Management 2007, 3:833-844

Published Date: 15 January 2008

Obesity management: Update on orlistat

Belinda S Drew, Andrew F Dixon, John B Dixon

Vascular Health and Risk Management 2007, 3:817-821

Published Date: 15 January 2008

A review of nateglinide in the management of patients with type 2 diabetes

Nicholas Tentolouris, Christina Voulgari, Nicholas Katsilambros

Vascular Health and Risk Management 2007, 3:797-807

Published Date: 15 January 2008

Acute coronary syndrome associated with Churg-Strauss syndrome

Annette Doris Wagner, Gerd Peter Meyer, Markus Rihl, Anke Rathmann, Ulrike Wittkop, et al

Vascular Health and Risk Management 2007, 3:775-779

Published Date: 15 November 2007

Emergency endovascular repair of acute descending thoracic aortic dissection

Muhammad Anees Sharif, Mark Edward O’Donnell, Paul Henry Blair, Peter Kennedy

Vascular Health and Risk Management 2007, 3:769-773

Published Date: 15 November 2007

Determinants of outcome in patients eligible for thrombolysis for ischemic stroke

Valeria Caso, Maurizio Paciaroni, Michele Venti, Francesco Palmerini, Giorgio Silvestrelli, et al

Vascular Health and Risk Management 2007, 3:749-754

Published Date: 15 November 2007

Macro- and micronutrients in patients with congestive heart failure, particularly African-Americans

Kevin P Newman, Syamal K Bhattacharya, Ahmad Munir, Richard C Davis, Judith E Soberman, et al

Vascular Health and Risk Management 2007, 3:743-747

Published Date: 15 November 2007

Management of intracerebral hemorrhage

Ramandeep Sahni, Jesse Weinberger

Vascular Health and Risk Management 2007, 3:701-709

Published Date: 15 November 2007

Utilizing enoxaparin in the management of STEMI

Andrea Rubboli, Alessandro Capecchi, Giuseppe Di Pasquale

Vascular Health and Risk Management 2007, 3:691-700

Published Date: 15 November 2007

Optimizing combination treatment in the management of type 2 diabetes

Giuseppe Derosa, Salvadeo Sibilla

Vascular Health and Risk Management 2007, 3:665-671

Published Date: 15 November 2007

Nebivolol in the treatment of chronic heart failure

Angie Veverka, Jennifer L Salinas

Vascular Health and Risk Management 2007, 3:647-654

Published Date: 15 November 2007

Ischemic preconditioning: Protection against myocardial necrosis and apoptosis

Efstathios K Iliodromitis, Antigone Lazou, Dimitrios Th Kremastinos

Vascular Health and Risk Management 2007, 3:629-637

Published Date: 15 November 2007

Cholesterol lowering for secondary prevention: What statin dose should we use?

Kiranbir Josan, Finlay A McAlister

Vascular Health and Risk Management 2007, 3:615-627

Published Date: 15 November 2007

Are pleiotropic effects of statins real?

Alberto Corsini, Nicola Ferri, Michele Cortellaro

Vascular Health and Risk Management 2007, 3:611-613

Published Date: 15 November 2007

Aldosterone antagonism in heart failure

Alan B Miller

Vascular Health and Risk Management 2007, 3:605-609

Published Date: 15 November 2007

Comprehensive cardiovascular risk management – what does it mean in practice?

Leif Erhardt, Robert Moller, Juan García Puig

Vascular Health and Risk Management 2007, 3:587-603

Published Date: 15 November 2007

The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation

Paolo Gelosa, Mauro Cimino, Alice Pignieri, Elena Tremoli, Uliano Guerrini, et al

Vascular Health and Risk Management 2007, 3:567-577

Published Date: 15 November 2007

Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients

Ana T Rocha, Edison F Paiva, Arnaldo Lichtenstein, Rodolfo Milani Jr, Cyrillo Cavalheiro-Filho,
Francisco H Maffei

Vascular Health and Risk Management 2007, 3:533-553

Published Date: 15 September 2007

Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors

José Tuñón, José Luis Martín-Ventura, Luis Miguel Blanco-Colio, Nieves Tarín, Jesús Egido

Vascular Health and Risk Management 2007, 3:521-526

Published Date: 15 September 2007

Update on stents: Recent studies on the TAXUS® stent system in small vessels

Shuzou Tanimoto, Joost Daemen, Patrick W Serruys

Vascular Health and Risk Management 2007, 3:481-490

Published Date: 15 September 2007

Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study

Anja Vogt, Ursula Kassner, Ulrike Hostalek, Elisabeth Steinhagen-Thiessen

Vascular Health and Risk Management 2007, 3:467-479

Published Date: 15 September 2007

Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination

Sanjib Kumar Sharma, Piero Ruggenenti, Giuseppe Remuzzi

Vascular Health and Risk Management 2007, 3:453-465

Published Date: 15 September 2007

Bisoprolol in the treatment of chronic heart failure

Pascal de Groote, Pierre-Vladimir Ennezat, Fréderic Mouquet

Vascular Health and Risk Management 2007, 3:431-439

Published Date: 15 September 2007

Combined use of brain natriuretic peptide and C-reactive protein for predicting cardiovascular risk in outpatients with type 2 diabetes mellitus

Toshihiro Tsuruda, Johji Kato, Takahiro Sumi, Kazuya Mishima, Hiroyuki Masuyama, Hiroyuki Nakao, Takuroh Imamura, Tanenao Eto, Kazuo Kitamura

Vascular Health and Risk Management 2007, 3:417-423

Published Date: 15 September 2007

Occipital lobe infarctions are different

Halvor Naess, Ulrikke Waje-Andreassen, Lars Thomassen

Vascular Health and Risk Management 2007, 3:413-415

Published Date: 15 September 2007

Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis

Jerzy Krupinski, Marta M Turu, M Angels Font, Nesser Ahmed, Matthew Sullivan, Ana Luque, Francisco Rubio, Lina Badimon, Mark Slevin

Vascular Health and Risk Management 2007, 3:405-412

Published Date: 15 September 2007

Effect of continuous cisternal cerebrospinal fluid drainage for patients with thin subarachnoid hemorrhage

Yasunari Otawara, Kuniaki Ogasawara, Yoshitaka Kubo, Masayuki Sasoh, Akira Ogawa

Vascular Health and Risk Management 2007, 3:401-404

Published Date: 15 September 2007

Validation of four automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension

Jalil Belghazi, Ramzi N El Feghali, Thérèse Moussalem, Maya Rejdych, Roland G Asmar

Vascular Health and Risk Management 2007, 3:389-400

Published Date: 15 September 2007

Arterial Stiffness and Pharmacological Interventions – The TRanscend Arterial stiffNess Substudy (TRANS study)

Jirar Topouchian, Ramzi El Feghali, Bruno Pannier, Shuyu Wang, Feng Zhao, Karel Smetana, Koon Teo, Roland Asmar

Vascular Health and Risk Management 2007, 3:381-388

Published Date: 15 September 2007

Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy

Roland Asmar, Juan Garcia-Puig, Philippe Gosse, Yuri A Karpov, Peter Wilhem De Leeuw, Dieter Magometschniggs, Lajos Matos, Roland Schmieder

Vascular Health and Risk Management 2007, 3:371-380

Published Date: 15 September 2007

PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study

Erland Erdmann, John Dormandy, Robert Wilcox, Massimo Massi-Benedetti, Bernard Charbonnel

Vascular Health and Risk Management 2007, 3:355-370

Published Date: 15 September 2007

Severe supraaortal atherosclerotic disease resembling Takayasu’s Arteritis

Bernhard Kis, Thomas Liebig, Peter Berlit

Vascular Health and Risk Management 2007, 3:351-354

Published Date: 15 July 2007

Noninvasive measurements of arterial stiffness: Repeatability and interrelationships with endothelial function and arterial morphology measures

Corey J Huck, Ulf G Bronas, Eric B Williamson, Christopher C Draheim, Daniel A Duprez, Donald R Dengel

Vascular Health and Risk Management 2007, 3:343-349

Published Date: 15 July 2007

Management of acute coronary syndromes with fondaparinux

Harm Wienbergen, Uwe Zeymer

Vascular Health and Risk Management 2007, 3:321-329

Published Date: 15 July 2007

Multivariate risk assessment and risk score cards in hypertension

Giuliano Tocci, Valentina Valenti, Sebastiamo Sciarretta, Massimo Volpe

Vascular Health and Risk Management 2007, 3:313-320

Published Date: 15 July 2007

Rimonabant for treating tobacco dependence

Michael B Steinberg, Jonathan Foulds

Vascular Health and Risk Management 2007, 3:307-311

Published Date: 15 July 2007

Risk reduction with clopidogrel in the management of peripheral arterial disease

Keshav R Nayak, Jeffrey J Cavendish

Vascular Health and Risk Management 2007, 3:289-297

Published Date: 15 July 2007

Editorial: What future for vascular neurosurgery? || FREE PAPER ||

Matthew Crocker, Christos Tolias

Vascular Health and Risk Management 2007, 3:243-244

Published Date: 15 July 2007

Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination

Andreas Pfützner, Birgit Wilhelm, Thomas Forst

Vascular Health and Risk Management 2007, 3:211-220

Published Date: 15 May 2007

Sirolimus-eluting coronary stents: a review

Alexandre Abizaid

Vascular Health and Risk Management 2007, 3:191-201

Published Date: 15 May 2007

Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2

Allen J Taylor, Daming Zhu, Lance E Sullenberger, Hyun J Lee, Jeannie K Lee, Karen A Grace

Vascular Health and Risk Management 2007, 3:159-164

Published Date: 15 March 2007

Overweight, physical activity and high blood pressure in children: a review of the literature

Brian Torrance, K Ashlee McGuire, Richard Lewanczuk, Jonathan McGavock

Vascular Health and Risk Management 2007, 3:139-149

Published Date: 15 March 2007

Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy

Christoph Schindler, Peter Bramlage, Wilhelm Kirch, Carlos M Ferrario

Vascular Health and Risk Management 2007, 3:125-137

Published Date: 15 March 2007

Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis

Peter J Little, Mandy L. Ballinger, Narin Osman

Vascular Health and Risk Management 2007, 3:117-124

Published Date: 15 March 2007

Management of atrial fibrillation

Puneet Kakar, Christopher J Boos, Gregory YH Lip

Vascular Health and Risk Management 2007, 3:109-116

Published Date: 15 March 2007

Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels

Jutta Dierkes, Claus Luley, Sabine Westphal

Vascular Health and Risk Management 2007, 3:99-108

Published Date: 15 March 2007

Trandolapril/verapamil combination in hypertensive diabetic patients

José A García Donaire, Luis M Ruilope

Vascular Health and Risk Management 2007, 3:77-82

Published Date: 15 March 2007

Foot ulcers in the diabetic patient, prevention and treatment

Stephanie C Wu, Vickie R Driver, James S Wrobel, David G Armstrong

Vascular Health and Risk Management 2007, 3:65-76

Published Date: 15 March 2007

Cardiometabolic aspects of polycystic ovarian syndrome

Li Wei Cho, Harpal S Randeva, Stephen L Atkin

Vascular Health and Risk Management 2007, 3:55-63

Published Date: 15 March 2007

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial

Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, Christian Torp-Pedersen

Vascular Health and Risk Management 2007, 3:31-37

Published Date: 15 March 2007

Moexipril and left ventricular hypertrophy

George S Chrysant, PK Nguyen

Vascular Health and Risk Management 2007, 3:23-30

Published Date: 15 March 2007

Erratum

Vascular Health and Risk Management 2006, 2:515-515

Published Date: 15 December 2006

Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients’ risk level

Daria Roccatagliata, Fausto Avanzini, Lara Monesi, Vittorio Caimi, Davide Lauri, Paolo Longoni, Roberto Marchioli, Massimo Tombesi, Gianni Tognoni, Maria Carla Roncaglioni, on behalf of the Collaborative Group Risk and Prevention Study

Vascular Health and Risk Management 2006, 2:507-514

Published Date: 15 December 2006

Hypothyroidism in coronary heart disease and its relation to selected risk factors

Otto Mayer Jr, Jaroslav Šimon, Jan Filipovský, Markéta Plášková, Richard Pikner

Vascular Health and Risk Management 2006, 2:499-506

Published Date: 15 December 2006

Assessment of cognitive function in patients with essential hypertension treated with lercanidipine

J Tisaire-Sánchez, J Roma, Ignacio Camacho-Azcargorta, J Bueno-Gómez, J Mora-Maciá, Angel Navarro

Vascular Health and Risk Management 2006, 2:491-498

Published Date: 15 December 2006

Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects

Liliana Legedz, Giampiero Bricca, Pierre Lantelme, Marie-Odile Rial, Pierre Champomier, Madeleine Vincent, Hugues Milon

Vascular Health and Risk Management 2006, 2:485-490

Published Date: 15 December 2006

Outcomes of coronary artery bypass graft surgery

Anna Louise Hawkes, Madeleine Nowak, Benjamin Bidstrup, Richard Speare

Vascular Health and Risk Management 2006, 2:477-484

Published Date: 15 December 2006

Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment

Leila Fernandes Araujo, Alexandre de Matos Soeiro, Juliano Lara Fernandes, Antônio Eduardo Pesaro, Carlos V Serrano Jr

Vascular Health and Risk Management 2006, 2:465-475

Published Date: 15 December 2006

The impact of health literacy on cardiovascular disease

Richard S Safeer, Catherine E Cooke, Jann Keenan

Vascular Health and Risk Management 2006, 2:457-464

Published Date: 15 December 2006

Sexual function in hypertensive patients receiving treatment

Thorsten Reffelmann, Robert A Kloner

Vascular Health and Risk Management 2006, 2:447-455

Published Date: 15 December 2006

Sildenafil in the treatment of pulmonary hypertension

Christopher F Barnett, Roberto F Machado

Vascular Health and Risk Management 2006, 2:411-422

Published Date: 15 December 2006

A review of levosimendan in the treatment of heart failure

Hulya Akhan Kasikcioglu, Nese Cam

Vascular Health and Risk Management 2006, 2:389-400

Published Date: 15 December 2006

Bivalirudin in percutaneous coronary intervention

Sam J Lehman, Derek P Chew

Vascular Health and Risk Management 2006, 2:357-363

Published Date: 15 December 2006

Management of cancer-associated venous thrombosis

Ozlem Er, Leo Zacharski

Vascular Health and Risk Management 2006, 2:351-356

Published Date: 15 December 2006

Metabolic syndrome: the danger signal in atherosclerosis

Patrick Mathieu, Philippe Pibarot, Jean-Pierre Després

Vascular Health and Risk Management 2006, 2:285-302

Published Date: 15 September 2006

Insulin detemir in the treatment of type 1 and type 2 diabetes

Jean-Christophe Philips, André Scheen

Vascular Health and Risk Management 2006, 2:277-283

Published Date: 15 September 2006

Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms

Sudesh Vasdev, Vicki Gill, Pawan K Singal

Vascular Health and Risk Management 2006, 2:263-276

Published Date: 15 September 2006

Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease

Raed Osman, Philippe L L’Allier, Nader Elgharib, Jean-Claude Tardif

Vascular Health and Risk Management 2006, 2:221-237

Published Date: 15 September 2006

Angiogenesis in cancer

Naoyo Nishida, Hirohisa Yano, Takashi Nishida, Toshiharu Kamura, Masamichi Kojiro

Vascular Health and Risk Management 2006, 2:213-219

Published Date: 15 September 2006

Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes

John Pullman, Tamara Darsow, Juan P Frias

Vascular Health and Risk Management 2006, 2:203-212

Published Date: 15 September 2006

Screening for popliteal aneurysms should not be a routine part of a community-based aneurysm screening program

Martin Claridge, Simon Hobbs, Clive Quick, Donald Adam, Andrew Bradbury, Teun Wilmink

Vascular Health and Risk Management 2006, 2:189-191

Published Date: 15 June 2006

Vascular risks and management of obesity in children and adolescents

Courtney J Jolliffe, Ian Janssen

Vascular Health and Risk Management 2006, 2:171-187

Published Date: 15 June 2006

Leptin and hypertension in obesity

Paco E Bravo, Stephen Morse, David M Borne, Erwin A Aguilar, Efrain Reisin

Vascular Health and Risk Management 2006, 2:163-169

Published Date: 15 June 2006

Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence

Craig S Patch, Linda C Tapsell, Peter G Williams, Michelle Gordon

Vascular Health and Risk Management 2006, 2:157-162

Published Date: 15 June 2006

Metabolic syndrome, inflammation and atherosclerosis

Rodolfo Paoletti, Chiara Bolego, Andrea Poli, Andrea Cignarella

Vascular Health and Risk Management 2006, 2:145-152

Published Date: 15 June 2006

The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure

Ovidio De Freitas, Oliver Lenz, Alessia Fornoni, Barry J Materson

Vascular Health and Risk Management 2006, 2:139-144

Published Date: 15 June 2006

Endovascular stent-graft placement for vascular failure of the thoracic aorta

Yoshihiko Kurimoto, Kiyofumi Morishita, Yasufumi Asai

Vascular Health and Risk Management 2006, 2:109-116

Published Date: 15 June 2006

Clinical implications of angiogenesis in cancers

Roberta WC Pang, Ronnie TP Poon

Vascular Health and Risk Management 2006, 2:97-108

Published Date: 15 June 2006

Evaluation of efficacy and safety of fixed dose lovastatin and niacinER combination in Asian Indian dyslipidemic patients: a multicentric study

Manoj Sharma, Deepika R Sharma, Vikram Singh, RB Panwar, HS Hira, Bishav Mohan, Naveen Kumar, SK Sharma, Rajeev Gupta

Vascular Health and Risk Management 2006, 2:87-93

Published Date: 15 March 2006

Effects of eprosartan on target organ protection

Alejandro de la Sierra

Vascular Health and Risk Management 2006, 2:79-85

Published Date: 15 March 2006

Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes

Catherine A Schnabel, Matthew Wintle, Orville Kolterman

Vascular Health and Risk Management 2006, 2:69-77

Published Date: 15 March 2006

Ximelagatran: direct thrombin inhibitor

Shir-Jing Ho, Tim A Brighton

Vascular Health and Risk Management 2006, 2:49-58

Published Date: 15 March 2006

Noninvasive assessment of preclinical atherosclerosis

Helen A Lane, Jamie C Smith, J Stephen Davies

Vascular Health and Risk Management 2006, 2:19-30

Published Date: 15 March 2006

Endothelial function in systemic lupus erythematosus: relationship to disease activity, cardiovascular risk factors, corticosteroid therapy, and coronary calcification

Elizabeth Turner, Victor Dishy, Cecilia P Chung, Paul Harris, Rosanna Pierce, Yu Asanuma, Annette Oeser, Tebeb Gebretsadik, Ayumi Shintani, Paolo Raggi, C Michael Stein

Vascular Health and Risk Management 2005, 1:357-360

Published Date: 15 December 2005

Efficacy and safety of atorvastatin in South Asian patients with dyslipidemia: an open label noncomparative pilot study

Jeetesh V Patel, Sandeep Gupta, Frank Lie, Elizabeth A Hughes

Vascular Health and Risk Management 2005, 1:351-356

Published Date: 15 December 2005

Prognostic factors for amputation or death in patients submitted to vascular surgery for acute limb ischemia

Clebes Fagundes, Flávio Danni Fuchs, Almondi Fagundes, Ronaldo A Poerschke, Maurício Z Vacaro

Vascular Health and Risk Management 2005, 1:345-349

Published Date: 15 December 2005

Optimal lipid modification: the rationale for combination therapy

James M Backes, Cheryl A Gibson, Patricia A Howard

Vascular Health and Risk Management 2005, 1:317-331

Published Date: 15 December 2005

Pathophysiology of tumor neovascularization

Mitsuko Furuya, Mariko Nishiyama, Yoshitoshi Kasuya, Sadao Kimura, Hiroshi Ishikura

Vascular Health and Risk Management 2005, 1:277-290

Published Date: 15 December 2005

Drug-eluting stent: a review and update

Thein Htay, Ming W Liu

Vascular Health and Risk Management 2005, 1:263-276

Published Date: 15 December 2005

Blood pressure and control of cardiovascular risk

Judith A Whitworth

Vascular Health and Risk Management 2005, 1:257-260

Published Date: 15 October 2005

Endothelium-dependent NO-mediated vasodilation in humans is attenuated by peripheral a1-adrenoceptor activation

Adriaan M Kamper, Anton JM de Craen, Rudi GJ Westendorp, Gerard J Blauw

Vascular Health and Risk Management 2005, 1:251-256

Published Date: 15 October 2005

Serial changes in plasma levels of cytokines in patients with coronary artery disease

Roberto H Heinisch, Carlos R Zanetti, Fabiano Comin, Juliano L Fernandes, José A Ramires, Carlos V Serrano Jr

Vascular Health and Risk Management 2005, 1:245-250

Published Date: 15 October 2005

Optimal blood pressure level and best measurement procedure in hemodialysis patients

Annie Saint-Remy, Jean-Marie Krzesinski

Vascular Health and Risk Management 2005, 1:235-244

Published Date: 15 October 2005

Ultrasound assessment of endothelial function in children

Mikko J Järvisalo, Olli T Raitakari

Vascular Health and Risk Management 2005, 1:227-233

Published Date: 15 October 2005

Premature coronary artery disease in Indians

Meenakshi Sharma, Nirmal Kumar Ganguly

Vascular Health and Risk Management 2005, 1:217-225

Published Date: 15 October 2005

Actions of calcium channel blockers on vascular proteoglycan synthesis: relationship to atherosclerosis

Soniya Survase, Melanie E Ivey, Julie Nigro, Narin Osman, Peter J Little

Vascular Health and Risk Management 2005, 1:199-208

Published Date: 15 October 2005

Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome

Hadi AR Hadi, Cornelia S Carr, Jassim Al Suwaidi

Vascular Health and Risk Management 2005, 1:183-198

Published Date: 15 October 2005

Lercanidipine in hypertension

Claudio Borghi

Vascular Health and Risk Management 2005, 1:173-182

Published Date: 15 October 2005

Treatment of high blood pressure and gain in event-free life expectancy

Behrouz Kassaï, Jean-Pierre Boissel, Michel Cucherat, Florent Boutitie, François Gueyffier

Vascular Health and Risk Management 2005, 1:163-169

Published Date: 15 July 2005

Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia

Genovefa D Kolovou, Katherine Anagnostopoulou, Nektarios D Pilatis, Klelia D Salpea, Ioannis S Hoursalas, Ilias Petropoulos, Helen I Bilianou, Dennis V Cokkinos

Vascular Health and Risk Management 2005, 1:155-161

Published Date: 15 July 2005

Nonsteroidal antiinflammatory drugs are associated with increased aortic stiffness

Martin Claridge, Simon Hobbs, Clive Quick, Nick Day, Andrew Bradbury, Teun Wilmink

Vascular Health and Risk Management 2005, 1:149-153

Published Date: 15 July 2005

Knowledge of risk factors and warning signs of stroke

Marcus B Nicol, Amanda G Thrift

Vascular Health and Risk Management 2005, 1:137-147

Published Date: 15 July 2005

A new paradigm of cardiovascular risk factor modification

Muhammad Firdaus, Jeffery M Asbury, Dwight W Reynolds

Vascular Health and Risk Management 2005, 1:101-109

Published Date: 15 July 2005

Relationship between arterial stiffness and heart rate recovery in apparently healthy adults

Ding-Yu Fei, Ross Arena, James A Arrowood, Kenneth A Kraft

Vascular Health and Risk Management 2005, 1:85-89

Published Date: 15 April 2005

Folic acid: a marker of endothelial function in type 2 diabetes?

Arduino A Mangoni, Roy A Sherwood, Belinda Asonganyi, Emma L Ouldred, Stephen Thomas, Stephen HD Jackson

Vascular Health and Risk Management 2005, 1:79-83

Published Date: 15 April 2005

Ongoing clinical trials of the pleiotropic effects of statins

Jean Davignon, Lawrence A Leiter

Vascular Health and Risk Management 2005, 1:29-40

Published Date: 15 April 2005

Editorial ||FREE PAPER||

Reza Tabrizchi

Vascular Health and Risk Management 2005, 1:1-1

Published Date: 15 April 2005